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Abstract 
 
Nitro-containing compounds are an important class of chemicals with high value in industry and 
medicine. Several of these compounds are produced naturally in many different species; however, 
several key aspects of their biosynthesis, and the discovery of further nitro compounds are topics of 
active research. The prototypical enzyme for N-oxygenation of arylamines is the protein, AurF, from 
Streptomyces thioletus. Partial characterization of AurF has already been performed, but in this thesis, a 
more complete characterization of this enzyme is performed for eventual work in protein engineering. 
The activity of the enzyme was increased more than 600-fold via optimizing reaction pH and 
supplementing the chemical mediators reductants phenzazine methosulfate(PMS) and NADH. Alanine 
scanning and substrate specificity studies were performed to identify key residues and mechanistic 
information of the protein. The electron transfer mechanism of AurF was also studied, resulting in a 
better understanding of the kinetics of each important step in the reaction mechanism.  Finally, an in 
vivo screening method for directed evolution was developed and validated. Screening was performed to 
find mutants with activity towards meta-aminobenzoic acid.  The resultant positive hits from the initial 
screening are to be confirmed and characterized later.  
In parallel, based on the bioinformatics search for AurF analogs, the mangotoxin gene cluster 
from Pseudomonas syringae was identified as possibly making a nitroaromatic product. Product solation 
and identification of this cluster’s gene product were attempted based on heterologous expression of 
the cluster in E. coli, and fermentation studies in the native host. To that end, the gene cluster was 
recloned in a variety of constructs using several methods such as DNA assembler, Golden Gate and 
Gibson assembly. Expression of the pathway genes was observed in E. coli, while feeding studies 
confirmed the production of nitroaromatic compounds from the cluster. A product detection method 
based on reduction/diazotization was developed in order to find the putative product. 
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Chapter 1: Introduction 
 
1.1. Nitro Products: An Opportunity for Synthetic Biology 
One of the goals of synthetic biology is to produce a given compound in high yield and purity 
through biosynthetic processes.. 1,2Similar to the philosophy of total chemical synthesis, where an easily 
available precursor is converted to a more desirable compound, the biological approach to create a 
compound of interest is to introduce wild type or engineered enzymes to catalyze reactions of interest. 
This has been applied successfully in many cases, such as in production of biofuels, chemicals and 
natural products.3,4 A biology-based approach has several advantages, such as being able to use mild 
reaction conditions, avoiding toxic byproducts and organic solvents, and being able to leverage the 
exquisite specificity of enzymes to enforce desired stereochemistry. However, the toolkit for 
chemosynthetic biology is limited by the reactions which can be found in nature. There is a significant 
need for unique reactions and ways to install functional groups through biocatalysis. Thus, discovery of 
new biosynthetic reactions and characterization of the involved enzymes are topics that are attracting 
significant attention.  
The formation of nitro compounds is one such reaction. Nitro compounds are industrially relevant as 
feedstock chemicals, usually as precursors for other industrially important amines. However, the 
industrial processes for making these compounds typically involve strong acids and harsh reaction 
conditions, making cleanup and waste disposal difficult. As an example, the production of 
trinitrotoluene involves progressively harsher conditions, as the nitro group is deactivating towards 
further electrophilic substitution (Figure 1.1A).5 Contamination of chemical sites is a common 
occurrence from these processes, eventually requiring expensive remediation procedures. 6 There are 
significant health risks involved with these environments, as nitro compounds have been found to be 
carcinogenic. 7 Although large-scale nitro compound production is a man-made phenomenon, bacteria 
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have evolved to consume and detoxify these compounds. Conversely, several different nitro compounds 
are biosynthesized by a variety of species as antibiotics, antifungals, and other defensive compunds.7,8 
Chloramphenicol, a common antibiotic which inhibits protein synthesis, was originally discovered in 
Streptomyces venezuelae.9 Another Streptomyces species produces aureothin, a polyketide antifungal 
compound which uses p-nitrobenzoic acid as a starter unit. 10,11 However, only recently has the detailed 
information on the biosynthesis of these compounds been available. Thus, work in this thesis includes 
characterizing enzymes and biosynthetic clusters involved in nitro compound biosynthesis. 
1.2. Biological Mechanisms of Nitration and N-Oxygenation 
A) 
 
B) 
 
C) 
 
Figure 1.1. Methods of nitration industrially and biosynthetically.  A) Synthesis of TNT by electrophilic aromatic substitution. 
Increasingly harsh conditions are necessary for additional nitration. B) Mechanism for electrophilic aromatic substitution. 
Formation of a nitronium ion allows for electrophilic addition to benzene. C) N-oxygenation of amines through successive 
two-electron oxidations.  
 
 
Several mechanisms of nitro compound formation have been observed in nature. Electrophilic 
substitution reactions, which operate by formation of nitric acid or by nitrogen radicals have been 
observed in several compounds, and are the main mechanisms on which large-scale industrial nitro 
compounds are made (Figure 1A and B).6,7,12 As the nitronium ion is highly reactive and produced under 
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conditions of oxidative stress, several health-related issues such as protein nitration, allergic reactions 
and unwanted mutagenesis have been associated with this type of nitration. 6,12,13 Although this method 
has the advantage of simplicity, it can be hard to direct the nitronium ion to react specifically at a given 
position unless directed by an enzyme. An Antarctic psychotropic bacterium Salegentibacter sp. strain 
T436 produces several nitroaromatic compounds, and it is thought the nitration proceeds via these 
mechanisms.14  
A second common mechanism of nitration involves oxidation of a preexisting amine to more 
oxidized functionalities (Figure 1.1C). Hydroxylamine and nitroso compounds are intermediates  toward 
the production of nitroaromatic compounds. These reactions can be reversed to detoxify nitroaromatic 
compounds, enabling several organisms such as Pseudomonas and Rhodococcus to survive in and 
remediate contaminated soils. 7,15 Although these reactions do not proceed through a radical 
mechanism, the hydroxylamine and nitroso intermediates are still very reactive, and can be toxic to the 
host cells.  
Several methods of N-oxygenation have been observed in nature. Commonly, metalloproteins 
have been able to perform N-oxygenation. A variety of metals and functional moieties have been shown 
to catalyze this reaction, from diiron monooxygenases (AurF, CmlI), copper-based tyrosinases, and even 
P450-type proteins.  7,9,15–17 While the exact reaction mechanism differs depending on the identities of 
the metal and prosthetic group, the mechanism used is still stepwise oxygenation of an amine precursor. 
In contrast to metal-dependent hydroxylation, fully organic flavin-dependent monooxygenases have 
also been observed to perform N-oxygenation. The synthesis of nitrosugars everninomicin and 
rubradirin, the antifungal pyrrolnitrin and the N-oxide alkaloid senecionine begins from oxidation of a 
free amine through formation of a hydroperoxo intermediate in the flavin, which proceeds to 
hydroxylate their substrates, respectively. 18–20  
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1.3. Di-iron Arylamine N-Oxygenases  
One class of N-oxygenases under significant study are the di-iron monooxygenases, best exemplified 
by AurF. AurF is a member of the ferritin-like proteins such as ribonucleotide reductase and aldehyde 
decarbonylase, which catalyze the oxidation of various substrates. 21,22 Currently, there are three unique 
compounds known to involve AurF-type monooxygenases; aureothin and its derivatives, 
chloramphenicol, and althiomicin (Figure 1.2). 9,10,23 In all these compounds, an aromatic ring or a 
conjugated system contains an amine precursor, which is then oxygenated into either a nitroaromatic 
compound, or an oxime. These proteins are similar in size (~320 aa) and share several conserved 
residues involved in electron transfer and catalysis.9,23 These enzymes are thought to use reduced 
ferredoxin as the source for their electrons, and could possibly be reconstituted in an E. coli host. 9,21,24 
As there is not a lot of structural, mechanistic and biochemical characterization performed for these 
proteins, much of their activity is still unknown. These factors make them currently unattractive as 
biocatalysts, and thus significant protein engineering and directed evolution studies have yet to be 
performed for this class of enzymes.  
 
Figure 1.2: Products of gene clusters which contain di-iron N-oxygenase similar to AurF  
 
 Although all the previously mentioned compounds have been initially isolated in streptomyces 
species, the genes encoding for these N-oxygenase enzymes have been found in several different 
species.23,25 Pseudomonas, Rhodococcus and Burkholderia species contain several of these AurF-like 
enzymes associated with either non-ribosomal peptide synthetases, or polyketide synthetases. It is not 
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surprising to see these compounds in these hosts, as these organisms can survive in soils contaminated 
with polynitroaromatics such as TNT and munitions waste.6,7,26 In these organisms, several putative nitro 
gene products have been isolated, but have not been linked to any gene clusters. Thus, linking the 
production of these nitro compounds to their putative gene clusters could be potentially useful in 
synthetic biology, first as a demonstration of product discovery, and second as  as a means to 
characterize and isolate useful biosynthetic transformations.  
1.4. Project Overview 
This thesis focuses on the characterization and reconstitution of an enzyme and a gene cluster which 
have N-oxygenase activity. To that end, AurF, the prototypical enzyme of its class, has been fully 
characterized using biochemical methods. Conditions were found which enabled it to work much faster 
(>600x) compared to the previous reconstitution efforts. Additional work was performed to develop a 
system for AurF directed evolution to accept other substrates of interest.  This work paves the way for 
future engineering of N-oxygenases with desired characteristics and substrate specificity.  
Using the gene sequence of AurF as a probe leads to the second part of this thesis, focusing on the 
reconstitution of a gene cluster from Pseudomonas syringae which encodes for a putative compound 
mangotoxin. The goal of this project was to combine the Zhao group’s experience in synthetic biology 
with the knowledge we have of enzymatic arylamine N-oxygenation to discover new compounds and 
pathways. Cloning and heterologous expression of the genes in this cluster were performed, and 
enzymatic activity was demonstrated in vivo. In total, the methodology, results and future work shown 
in this thesis can lead to generalizable advances in the discovery and characterization of these enzymes 
and gene clusters. 
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Chapter 2: Characterization of the N-oxygenase AurF 
2.1. Introduction 
The nitro group is a common functional group present in many industrially important 
commodity chemicals, pharmaceuticals, and explosives. Nitro-containing compounds in the 
environment are typically encountered as pollutants and xenobiotic compounds, and have been 
implicated in several types of DNA damage and cancer; thus, biodegradation of these compounds is an 
important area of research. However, the biosynthesis of naturally occurring nitro compounds is not as 
well understood. Several important nitro-containing natural products such as stephanosporin, 
pyrrolonitrin, and chloramphenicol, are produced by various organisms as antibiotics, signaling 
molecules or other types of metabolites (Figure 2.1A).1,2 The mechanism for installation of nitro groups 
in several compounds is known, such as the production of nitrotyrosine through free radical reactions of 
peroxonitrate, and the N-oxygenation of pyrrolonitrin by the enzyme PrnD via hydroxylamine and 
nitroso intermediates.1–3 Much of the interest in biosynthetic nitration is due to the gentle conditions 
and benign wastes produced in comparison to the harsh conditions necessary for chemical nitration. 
Additionally, enzyme-based nitration provides a way to precisely control regiospecificity, a task that can 
be sometimes difficult in chemical synthesis. Therefore, characterization of enzymes which catalyze 
nitro group formation is of interest for green chemistry, biochemical synthesis and in the development 
of pharmaceuticals and niche chemicals. 
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Figure 2.1: (A) Nitro-containing compounds derived from natural sources.  (B) N-oxygenation catalyzed by AurF proceeds 
via hydroxylamine and possibly nitroso intermediates, with nitro product serving as the starter unit for biosynthesis of the 
polyketide aureothin. 
 
AurF is a diiron monooxygenase from Streptomyces thioletus that catalyzes the production of p-
nitrobenzoic acid (PNBA) from p-aminobenzoic acid (PABA) via p-hydroxylaminobenzoic acid (PHABA). 
This precursor is used as a starter unit by S. thioletus for the synthesis of the polyketide antibiotic 
aureothin. Like PrnD, N-oxygenation is the mechanism used by AurF (Figure 2.1B). Several properties of 
the enzyme such as its regiospecificity, mild reaction conditions, heterologous expression and activity in 
Escherichia coli, have made this enzyme attractive for biotechnology applications and as a complement 
to chemical syntheses. Much work has been done by the Zhao, Bollinger, and Hertweck groups in 
characterizing this enzyme such as determination of the active site metal and crystal structure, 
elucidation of its mechanism, and progress in understanding its substrate specificity.2,4–11 However, 
several pieces of data are contradictory, including substrate specificity of the enzyme as well as 
mechanistic considerations. Additionally, much of the literature data comes from the use of a 
manganese-enriched form of AurF which has a different active site structure compared to the diiron 
enzyme.4,11,12 Finally, the low activity of AurF has also hampered its characterization. Thus, the work 
done in this chapter is the characterization of AurF with optimized assay conditions, mutagenesis of 
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active site residues, and analysis of its substrate specificity.  An additional focus in this chapter is the 
development of a screening method to detect AurF mutants with activity towards desired unnatural 
substrates. Previous work done in the Zhao lab focused on evolving AurF towards N-oxidation of 1,3,5-
triaminobenzene with 1,3-phenylenediamine as an intermediate evolutionary step.13 This inspired the 
development of a new, generalizable screening method useful for N-oxygenase engineering. This 
method was validated and tested with several substrates, with preliminary screening performed to test 
the effectiveness of the assay.  
2.2. Protein Quantification, Reconstitution and pH Dependence  
A significant part of the work in this thesis was done with enzyme quantified via the Bradford protein 
assay due to issues of convenience. However, we discovered that AurF quantified by the Bradford assay 
gives approximately twice the enzyme concentration compared to the previously used commercial BCA 
kit (Figure 2.2) using identical standards. This is somewhat unusual but not unexpected; it has been 
reported in literature that the Bradford protein assay exhibits varying responses to different proteins, 
and another report has shown that the nonheme diiron monooxygenase MiaE exhibits an 
overestimation with the Bradford assay of a factor of 1.16.14,15 In this paper, we report all our specific 
activity, kcat and kcat/Km multiplied by a correction factor of 2.05 (Figure 2.2) to be consistent with the 
BCA assay used in previous AurF literature; however we report enzyme concentrations based on the 
Bradford assay.4 
 
 
Bradford Assay 
(ug/mL) 
BCA Assay 
(ug/mL) 
Bradford/BCA 
Ratio 
10X Dilution 782 ± 11 459 ± 5 1.70 ± 0.03 
20X Dilution 499 ± 4 257 ± 4 1.94 ± 0.04 
40X Dilution 247 ± 0 99 ± 5 2.50 ± 0.12 
 
Averaged Ratio of Bradford / BCA = 2.05 + 0.41(SD) 
Figure 2.2. Quantification of AurF using Bradford and BCA assays. Assay was repeated in duplicate. No significant 
contamination can be observed after purification upon loading 10 (left) and 20 µL (right) of diluted enzyme. 
 
 
11 
 
 Early reports from 1965 regarding AurF suggested that the pH optimum of the enzyme occurred 
under neutral conditions. However, this involved an in vivo assay using whole cells of S. thioletus, the 
results of which more likely reflect the pH dependence of the organism rather than actual enzymatic 
activity.16 Under our assay conditions using PMS/NADH as a reduction system, the optimum pH of AurF 
was determined to be pH 5.5 with significant activity seen between pH 4.5 and 6.5 (Figure 2.3A) . 
However, when AurF was tested at pH 7.5 and 5.5 with either ferredoxin/ferredoxin-NADP+ reductase 
(Fd/FDR) or H2O2 as reductants, the activity of AurF was fairly constant, and did not change as 
significantly as in the case of PMS/NADH (Figure 2.4). pH 5.5 as an optimum is unusual, given that a 
recent paper by Sazinsky et al. on an N-oxygenase (23% sequence identity to AurF) from Pseudomonas 
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                                                  C)                
 
Figure 2.3 A) pH dependence of AurF with 100 µM of PABA. B) Specific activity of AurF and W35F mutant using various 
reductants using 250 µM of PABA. The effect of catalase on PMS/NADH was also examined. C) Reaction cycle for AurF.  
Assuming the peroxide shunt (step B) is slow compared to step C, Ar-NHOH will not build up. However, if step A is relatively 
fast compared to C, then accumulation of NHOH will occur. 
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syringae showed a pH optimum of 9.0-9.5, albeit using peroxide as a reductant.17 While the increased 
activity of AurF using PMS/NADH at lower pH could simply be due to more favourable protonation / 
redox state of PMS at that pH, the increased turnover seems to be related to the protonation of AurF’s 
sidechain residues. Fitting the pH profile of AurF to an equation (see Experimental section) gives the pKa 
of catalytically or structurally important residues, and it was found that these residues had pKas of 4.6 
and 6.4, which likely correspond to an aspartate/glutamate and a histidine residue, respectively.   
While the pH optimum of AurF at pH 5.5 using PMS/NADH is unmistakable, it is unlikely that this is 
the pH at which the reaction occurs in vivo. Although Streptomyces species have been shown to be able 
to grow and sporulate under low pH conditions depending on media conditions and strains, the internal 
pH of the cell should be close to neutral or somewhat basic (pH 6.5-8.5).18,19 Additionally, required 
accessory proteins such as ferredoxin may be show lesser or no activity  at this lower pH (although this 
was compensated for in vitro with the large amounts of ferredoxin and reductase used). Finally, a 
related enzyme CmlI, which also catalyzes a similar N-oxidation in the chloramphenicol biosynthesis 
pathway, does not show increased activity at this pH, and several other structurally-related diiron 
enzymes have been found to have optimal pH values at physiological values.20–22. At this point, it is likely 
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Figure 2.4. Activity of AurF using various electron mediators at pH 5.5 and 7.5 A concentration of 250 µM PABA was used 
for the assay. Activity was measured in triplicate, with error bars indicating standard deviations.  
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that some combination of both enzymatic features of AurF and the redox properties of PMS that provide 
this pH optimum.  
2.3. Kinetic Characterization 
AurF was characterized at pH 5.5 to have a Km of 14.7 ± 1.1 µM, a kcat of 97.4 ± 11.1 min
-1 and a 
kcat/Km of 6.6 ± 0.8 µM
-1 min-1 (Figure 2.5).  This is interesting in comparison to data reported in literature 
at pH 7.5, with a Km of 8.89 ± 0.87 μM, kcat of 5.04 ± 0.22 min
−1, and kcat/Km of 0.57 ± 0.03 min
−1μM−1.4 
The values for Km are similar at both pH suggesting no major changes in the active site architecture over 
different pH, however the 19-fold increase in kcat for the pH 5.5 condition compared to the pH 7.5 data 
suggests that a proton transfer is rate-limiting.  
Several possibilities can account for this increase in kcat at lower pH. The proposed mechanism of 
AurF as developed by Bollinger et al. requires the formation of a hydroperoxide bound to the diiron 
center of the protein.6,8 The initial peroxo complex can be formed by reaction of oxygen and Fe2(II/II), 
and subsequently be protonated to the hydroperoxo intermediate. In this mechanism, attack of the 
aromatic amine on the hydroperoxo electrophile could enable the formation of the initial hydroxylamine 
intermediate of PABA. Although this process could also proceed with nucleophilic attack on the peroxo 
complex and subsequent protonation, the hydroperoxo species is a stronger electrophile, and would 
more readily be attacked by the amine nucleophile. Another case is the possible protonation of active-
site carboxylates and histidines affecting either the reaction or electron transfer pathway. Several 
aspartate, glutamate and histidine residues are found in the active site of AurF, and may perform some 
catalytic roles relying on proton transfer. The pKas of these residues are approximately 4 and 6 for 
aspartate/glutamate and histidine respectively, and their proximity to both the diiron cluster and the 
active site cavity suggest their importance in the activity of the enzyme. Residue E196 binds to one of 
the iron atoms as a unidentate ligand, and results from literature suggest that it may function as a 
general base to abstract protons generated by the reaction.6,8 Recent modelling work by Jayapal and 
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Rajaraman has demonstrated that E196 is protonated in the oxidized and mix-valence forms of diiron 
AurF.12 Alanine mutations of these residues have been shown to deactivate the enzyme, underlying their 
importance.8,23  
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Figure 2.5. Michaelis-Menten Assay for AurF at pH 5.5. PABA concentrations were varied from 5-100 µM, with each 
datapoint measured in triplicate. Error bars indicate one standard deviation. 
 
 Although the N-oxygenation activity of AurF has been demonstrated in several labs, the specific 
activity measured in our case is typically much higher compared to results from other labs. Notably, the 
in vitro specific activity found in our conditions for the wildtype enzyme was 1.99 ± 0.27 and 0.148 ± 
0.053 µmol mg-1 min-1 ,at pH 5.5 and 7.5 respectively with 100 µM of PABA, while the highest activity 
seen in literature is 0.0032 µmol mg-1 min-1 at pH 7.5.4,11 We also assayed AurF using a peroxide-shunt 
method at pH 5.5 and found a specific activity of 0.0162 ± 0.0043 µmol mg-1 min-1, indicating that while 
the lower pH increases the activity of the enzyme (5-13X), the method for delivering reductive 
equivalents to the enzyme provides significantly higher enhancements to activity (50-122X). We 
previously attributed the differences in enzymatic activity between our results and results by Zocher et 
al. to the metal in the active site, but it may also be the case that the source of the reducing equivalents 
is more important.11 In experiments done by the Sazinsky and Hertweck groups, the source of electrons 
used for the assay is hydrogen peroxide at physiological or basic pH, using a peroxide shunt-type 
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mechanism to enable catalysis by the active site. However, it has been demonstrated for the diiron 
enzyme toluene 4-monooxygenase hydroxylase that the use of the peroxide shunt is ~600-fold slower 
than the use of the native electron mediator proteins.24 The reaction of PMS and NADH has been 
reported to produce superoxide and hydrogen peroxide, so to observe any contributions by a peroxide 
shunt mechanism, 50 units of catalase were added to a typical reaction system.25,26 No difference in 
activity was observed compared to reactions without catalase, indicating that the PMS/NADH system 
proceeds via a different mechanism than the peroxide-based method (Figure 2.3C). It has also been 
noted that the PMS/NADH system can perform hydroxylations of aromatic systems; however no such 
activity was observed in our reactions.22,23 
2.4. Active-site Mutagenesis Studies  
To determine which residues are important for catalysis or substrate recognition in AurF, alanine 
scanning was performed on several different residues in the active site (Figure 2.6A-E) .  In most cases, 
important trends could be observed, while in a few others, the activity relationship could not be easily 
defined. The crystal structure of diiron AurF gives several hints as to the structural role of important 
active site residues (Figure 2.6 A and B). The minor difference in Km over a 2 pH unit range suggests that 
the substrate recognition is dependent mostly on residues that do not change their ionization within the 
pH range of the enzyme. The only protonatable groups that do not complex the active metals are 
residues D135, D226, H143 and H223, and these four do not directly interact with the native substrate.  
Alanine mutation of residues directly surrounding the substrate  (Y93, V97, T100, N200, or R302) 
decreases the activity of AurF to 50% or less of the wildtype. Y93, N200 and R302 are responsible for 
recognition and binding the carboxylate end of the native substrate either directly or through water-
mediated contacts; however, none of these residues are completely essential for AurF activity, 
indicating some redundancy in the carboxylate recognition (Figure 2.6A and B). Comparison with several 
homologs shows that in general, residues with sidechains that can participate in hydrogen bonding are 
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favored at these positions (Table 2.1). Residues directly adjacent to the aromatic ring (V97 and T100) 
also show similar reductions in activity. These residues delineate the side and the top of the active site 
respectively, and mutation of these residues to alanine could allow the substrate to drift farther away 
from the diiron center or alter the structure of the active site. However, it could also be argued that an 
alanine mutation at these sites would not be a sufficiently drastic mutation from the previous mutation; 
V97 is situated facing the aromatic ring, and one methyl group could concievably be enough to align the 
substrate to the metal center. The counterpart of  the T100 residue in a few AurF homologs is actually 
alanine, (Table 2.1) which indicates  that at best that T100A is a conservative mutation. The relatively 
smaller decrease in AurF activity for this alanine mutant collaborates this fact. Thus, the decrease in 
activity for these mutants is surprising considering the relatively minor steric changes from the wildtype 
residues. 
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Figure 2.6. A and B) Structure of several important active-site residues in the AurF crystal structure (PDB ID: 3CHT). In all 
figures, active site water molecules are removed for clarity. C) Reorientation of the N94 sidechain creates a conserved 
three-residue motif coupled to the active site metal. D) Space-filling model of the AurF active site.  The model clearly shows 
2‘ substituents (green peg) are not sterically occulded compared to 3‘ substitutions (orange peg).Grey surface indicates a 
1.4 Å distance from the closest residue. D) Relative specific activity of various AurF mutants with 100 µM of PABA. Samples 
were tested at least 3 times. 
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Table 2.1. Protein sequences of AurF and several related enzymes.  
 
AurF ---------------MREEQPHLATTWAARGWVEEEGIGSATLGRLVRAWPRRAAVVNKA 45 
Kribbella flavida DSM 17836 -----------------------MTTFAG-----EDTIGLATLKRLADTWPRRAAVRRDL 32 
Haliangium ochraceum DSM 14365 ------------------------MQNAH-----EIKVNHQVIRGLANNWSKRCTIRSQK 31 
Burkholderia glumae BGR1 ---------MIIDDLQCSDADGLVHLPGLPSFDPADEAENAVISRLAGNWHRRSTVKRD- 50 
Rhodococcus opacus PD630 ---------MRDHTVAGASKDGHIQLAGLPPFDPRDPTENAVISRLVGNWHRRAAVKRA- 50 
Micromonospora sp. ATCC 39149 ----------------------------------MTITNTKLLTQLNHAWPRRATVCDMA 26 
Myxococcus xanthus DK 1622 MRRQTPPARLQTRNDSPLQLKADDGALVTQPLSGDSSAARRFLTRLGPHWARQAAVKNK- 59 
Pseudomonas syringae pv. tomato -------------------------------------------MSFIDAWEGRATIRTR- 16 
                                              :   *  :.::     
   
AurF DILDEWADYDTLVPDYPLEIVPFAEHPLFLAAEPHQRQRVLTGMWIGYNERVIATEQLIA 105 
Kribbella flavida DSM 17836 AIEGQAGEYDATLPDYPAHLMPFAEHPDFLAATPEQRDRVMSGMWLGYNQRVIATESLIA 92 
Haliangium ochraceum DSM 14365 YPFNADEQYDPNIPDYPHEMVPFWNHPRFESVSEDKKQMLLTWAWIVYNERTIAAEEYVA 91 
Burkholderia glumae BGR1 -EPDLDELFDAGRADYPEAIVPFRDHPTWQAMPDALRSRLLSWAWIAYNRHTVLAEQRVA 109 
Rhodococcus opacus PD630 -EPDVYALFDRDRPDFRDDMIPFRSHPIWQSLSDEMRSRLCSWGWVAYNRNTVLIEQRIA 109 
Micromonospora sp. ATCC 39149 -KFRVEGEFDPTRADYPAALVPFFTHDAIQRLDDPLRQAILTWGWIGYNRRTVAAEDLVV 85 
Myxococcus xanthus DK 1622 -EPSLTELLEPAKPDFAERLLPFRDHPTYQGLDEAMKRRVLSCGWLIYNERVVRVELDVV 118 
Pseudomonas syringae pv. tomato ---PRRIVENDEKLIYPLSRQPLVLSDTFTRECAHLRDYALVQSLYKFINDVVIFETEIV 73 
                   :     :     *:             :          : . .:  *  :. 
   
AurF EPAFDLVMHGVFPGSDDPLIRKSVQQAIVDESFHTYMHMLAIDRTRELR-KISERPPQPE 164 
Kribbella flavida DSM 17836 NPAFELVMQRVFPGSDDRVIQQTVQQSLVDESFHTYMHMMAVNRTCDLR-GIGERPKQPT 151 
Haliangium ochraceum DSM 14365 NPAFGLIMHDRFPGCATIDYKNSIQQSLIDEHFHTFMHINGIHRTKVTR-NITSAPKFPY 150 
Burkholderia glumae BGR1 NPAFALVMDGEFPGLGGQDMDIALAQAMVDEQYHTLMHINASALTRRKRGNPFPDSALPE 169 
Rhodococcus opacus PD630 NPAFELVIAGEYPGIGGQQLELAVAQAMVDEQYHTLMHINGSAVTRRMRQREFSDRVLPD 169 
Micromonospora sp. ATCC 39149 NPALNYLASEILAG-DDWVFTESVRQTLIDEHYHTLMHLSAIQRTRAQR-AITIDMELPM 143 
Myxococcus xanthus DK 1622 NPVCNDVLLSKLPGATSQAARESMAQALVDEAYHILLVVRACRLTREQR--GLEDLRLPV 176 
Pseudomonas syringae pv. tomato DKTARSIAKDNFAIRFPFACRYDAMTVVVDEDYHALVAMDFMQQTIALT--GIEPIQLPT 131 
       : .   :     .              ::** :*  : :     *             *  
  
AurF LVTYRRLRRVLADMPEQWERDIAVLVWGAVAETCINALLALLARDATIQPMHSLITTLHL 224 
Kribbella flavida DSM 17836 LITYRRLQAVLAEMTEQWQRDVAVLVWGAVAETCINALLGLIARDPGVQPMHSLITKLHL 211 
Haliangium ochraceum DSM 14365 SVTYRRLLEAQSKVSDTWEKELLTLTFAIVSEISINAYLDLIADNPTIQPTHRLIAKLHA 210 
Burkholderia glumae BGR1 SHTSRAHRRLRAHAAERWQRSLTTLAFATVSEISINAYLDLLADDHDIQVVNSTTAKLHN 229 
Rhodococcus opacus PD630 SHITTIHQQHLDRCGERWERSLTTLAFATVAEISINAYLELLADDQEIQVVNSTTVKLHN 229 
Micromonospora sp. ATCC 39149 SVTYRELEALKATLAEPWQRQLAAVVFATVAEISVNAFLDILADDETIQPQNRSVAQLHN 203 
Myxococcus xanthus DK 1622 VGVVRRMHARQASCAEAWQRDLVQLMTGVATEMCISRYLSLLSTASEIQAFNRVTTALHQ 236 
Pseudomonas syringae pv. tomato EIELSRAIPAALALAPEHLRSAVELICVAIAENTVTHDVAAFAKDDSVKQSIKGLMADHL 191 
                    :.   :     :*  :.  :  ::    ::         * 
 
   
AurF RDETAHGSIVVEVVRELYARMNEQQRRALVRCLPIALEAFAEQDLS--ALLLELNAAGIR 282 
Kribbella flavida DSM 17836 RDESAHGSVIVEVVKILYARMNQSQRDVLVRCLPPALESFGVQDPM--ALRIELRTAGIA 269 
Haliangium ochraceum DSM 14365 HDENAHAYLLQEAGKSLYLEMNDKQRRIFLQTLPIALEAFLAHDYS--AWEVILDFLKID 268 
Burkholderia glumae BGR1 RDEYCHASISDEMAKLVYDVLDPVKRRFFLDMLVAGLDAFVATDYS--TWEAIFRIEKVT 287 
Rhodococcus opacus PD630 RDEYCHASISAEMLKQVYEALPTDRRRFLLDEIVAGLEAFVAPDFT--TWETIMAFEGIA 287 
Micromonospora sp. ATCC 39149 RDEYAHSKTLGEISKVVFHRLNAKQKAFFIETLPVALRAFVAQDFS--MWEAILRQLGVP 261 
Myxococcus xanthus DK 1622 QDEASHVDLFGTLARDVFNALEPVQQEFVREILPLPWLWFSEGEAD--VWRSVLLQLGIP 294 
Pseudomonas syringae pv. tomato LDEGRHSGFWARLVRIYWHTAAEQDRECIARILPVFIAQYLTNDIQNGFDFTLIERLQVP 251 
  **  *        :  :       :  .   :      :   :         :    :  
 
   
AurF GAEEIVGDLRSTAGGTRLVRDFSGARKMVEQLGLDDAVDFDFPERPDWSPHTPR----- 336 
Kribbella flavida DSM 17836 KADDIVADVGRGGSGTKLVRDYSGTQRLVSELGLSGQVDFDFPDRPDWALTPPLDGREG 328 
Haliangium ochraceum DSM 14365 GASEILADSRSSSTNTSLSRDYSGLKKMAEELDVVDKLEFDFGN--------------- 312 
Burkholderia glumae BGR1 GWEKMLADVRAEKSGSRLVRDYSGLYSLMSDMNVLGDVDFDWGLAVTDK---------- 336 
Rhodococcus opacus PD630 GWEKAAAEVREAQTGTHLVQDHSGVHTLLSEMDVLDQVHFGWGERTDRQR--------- 337 
Micromonospora sp. ATCC 39149 NGAQIVRECRQPGSGNTLTRDYSGLHRLADELGILGQLDFEFAGTTRIAH--------- 311 
Myxococcus xanthus DK 1622 RADVMMDDCIANKLLSANERAMTDAQKFSEALGIDN-IHWDRAAALL------------ 340 
Pseudomonas syringae pv. tomato DPVRQALKAETLALSFPVNRHHPLIGNIMRFFKSSSMLDDPYVQRALAHYLPVQGSLQ- 309 
        .           :  .    :   :   . :.                     
 
Protein sequences for AurF and AurF-like proteins from several organisms. Highlighted in red are residues tested by alanine 
scanning. Residues marked with an asterisk are strictly conserved, while colons and periods indicate lesser degrees of 
conservation. Analysis was performed using the ClustalW2 server at http://www.ebi.ac.uk/Tools/msa/clustalw2/ 
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Modelling the rotamers of the N94 residue indicates that it may be involved in modulation of the 
redox activity of the active metals (Figure 2.6C) by orienting residues H143 and H223. Similar Asp-His 
couples mediate enzyme activity in peroxidases by modulating the pKa of the histidine residue.27,28  A 
BLAST search revealed that N94 is very strongly conserved through several probable AurF-type enzymes 
(Table 2.1), with the histidines are also being well-conserved. Substitution with alanine shows a sharp 
decrease of activity, however activity was not completely abolished, indicating that this residue may 
function in a structural role rather than as a modulator of electron transfer or redox. This is 
corroborated by the the observation that mutation of this residue to alanine caused an extreme 
decrease in solubility of the protein, suggestive of misfolding or instability. Similar results on AurF 
insolubility have been observed for residues related to the electron transfer of AurF (W35A and 
D135A).29 The activities of mutations R96A, I199A, L203A and F264 are more difficult to explain. The 
R96A mutant was previously reported in literature not to have activity in vivo, but according to our 
results, show around 75% activity.11 Zocher et al. rationalized that this arginine was important in the 
carboxylate binding of AurF and by removal of this functionality, the enzyme would be deactivated. This 
was supported by their crystal structure of the dimanganese version of AurF. However, in the diiron 
version of AurF, R96 is oriented away from the active site and does not directly bind the substrate. That 
is not to say that the residue plays no role in binding; it may assist in water-mediated contacts to the 
substrate, or be flexible enough to bind directly as evidenced by the small drop (around 25%) in activity 
compared to the wildtype. Residue I199 lines the cavity of the active site and separates it from the 
exterior of the protein. Although somewhat far from the substrate (6.8 Å), this residue walls off two 
water molecules that constrain the substrate. Mutation to alanine undermines the structure of the 
active site by creating an opening accessible to bulk solvent. Strongly conserved residue L203 forms the 
“floor” of the AurF active site, and mutating it to an alanine halves the activity of the enzyme. Similar to 
V97, the most likely role of this residue is to restrict the substrate in the active site. While Y93 and N200 
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provide significant hydrogen bonding to PABA to restrain it in the binding pocket, L203 complements 
this binding by providing a physical barrier below the substrate. Similar to R96, the positioning of F264 is 
quite different in the diiron and dimanganese versions of AurF. In the dimanganese enzyme, F264 aligns 
parallel to PABA and acts to align it to the active site, while in the diiron version, F264 is ~7 Å away from 
the substrate and is perpendicular to the PABA aromatic ring. As this residue is located next to R302, the 
F264A mutation allows the R302 residue to shift position, disrupting its water-mediated contacts with 
the substrate. This leads to the 50% decrease in activity for this mutant.    
2.5. Substrate Specificity  
The substrate specificity of AurF was tested with a variety of different compounds (Figure 2.7 A and 
B) at high substrate concentrations in order to saturate the enzyme. In general, our results show similar 
trends to literature but with higher activities due to the optimized assay conditions.10. In certain cases, 
significant exceptions were observed. The native substrate PABA (1) has a specific activity of 1.68 ± 0.25 
µmol/ mg-1 min-1 at a concentration of 250 µM of substrate, indicating some slight substrate inhibition 
compared to the data at 100 µM. From the data, compounds with substitutions at the 2’ position (2-6) 
retained higher activity compared to the 3’ position (7-11). Notably, compound 2 showed nearly 
identical activity to the native substrate.  Steric and electrostatic effects are the probable reason for the 
preference for 2’ substituents; approach of 3’ substituted compounds towards the metal center is 
disfavored by steric clashes with the residues surrounding the active site (Figure 2.6D), while the 2’ 
position is more open. The 2’ position shows a clear preference for electronegative substituents and 
several favorable hydrogen bonding interactions from Y93, R302, and N200 can provide additional 
stabilization. Compound 9 has been reported to be turned over by AurF10, however reliable rates could 
not be established as it spontaneously decomposed over the course of the assay, and putative 
hydroxylamine and nitro products were not observed in LC-MS analysis even when larger amounts of 
enzyme was added (data not shown). While compounds 7, 8, 10 and 29 show some activity and similar 
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sterics, it is not certain why 9 cannot be turned over, possibly due to oxidation or decay of the 
compound being faster than AurF-catalyzed reaction.  
Modification of the aromatic ring and the oxidizable amine provided interesting results. Replacement 
of the benzene ring with a pyridine showed no activity due to decreased nucleophilicity of the pyridine 
analog of PABA (13), while substitution of ring hydrogens with fluorine was accepted by AurF (12). 
Hydroxylation of a secondary amine (14) proceeds slowly, while a benzylic amine 15 does not to react. 
The result from 12 is surprising in the fact that the reaction proceeds well with the ring polarity 
completely reversed, and it was previously reported that this could not occur due to the strong electron-
withdrawing effects of the fluorines.10 As fluorine is an isostere of hydrogen, PABA and 12 are similar in 
size, and so the reduction in activity is not likely from steric factors. Activity towards 12 indicates that 
electronic state of the substrate is a major factor in the catalysis by AurF, but the enzyme itself can 
tolerate significantly different electronic states in its substrates. However, exaggerated electron-
withdrawing effects at the 2’ (6) or 3’ (11) position gives much decreased activity. As noted in literature 
and as demonstrated here, the enzyme can tolerate a range of +I and –I functional groups in the 
substrate.  
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Figure 2.7. A) Compounds tested with AurF in this study. B) Relative specific activity compared to PABA (1). Samples were 
tested in triplicate with rates from no-enzyme negative controls subtracted. 
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Substitution of the carboxylate end of PABA showed mixed results. In general, compounds containing 
a hydrogen bond acceptor (16-18, 24, 26) were turned over successfully by AurF, while substitutions 
with smaller functional groups (19-21) showed no activity. It may be assumed that compounds 19-21 are 
too far away to form effective interactions with hydrogen bonding residues such as Y93 and N200. For 
substrates 16-18, 24 and 26, the presence of a sp2-hybridized oxygen is enough to act as a hydrogen 
bond acceptor that stabilizes the binding of the substrate enough to be turned over by the enzyme. 
Substrate 25 may represent an upper limit in terms of size of the compound accepted by the enzyme.  In 
a surprising result, it was found that the regiospecificity of AurF is not strictly para as previously 
assumed.10  Although the ortho isomer of PABA 30 is not turned over as a substrate, compounds 24, 28 
and 29 showed some activity, with hydroxylamine and nitro products for 14 being confirmed by LC-MS 
(Figure 2.8-2.9). The rate of depletion of MABA (29) was only 0.1 % of the native substrate PABA, and 
could only be detected using large amounts of enzyme (20 uM). The nitrogen meta to the free amine in 
24 and 28 seems to be important to the binding of the substrates to the active site of AurF, since the 
related compound 27 showed no activity. Compounds 23 and 26 are structurally similar, however only 
the conversion of 26 is observed. Structural modeling of 24 and 28 gives no strong indication of the 
binding partners of these compounds, and the meta nitrogen seems not to have any significant binding 
partners in the minimized structures.  
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Figure 2.8 LC-MS data demonstrating turnover of (A) 3-amino acetanilide 24, (B) 4-aminoacetophenone 17 and (C) 4-
amino-2-chlorobenzoic acid 3 to their corresponding hydroxylamine intermediates. The nitro compound could not be 
observed on MS for 4-aminoacetophenone and 4-amino-2-chlorobenzoic due to the lack of ionizable groups, but could be 
detected on UV. 
 
A) 3-aminoacetanilide UV trace 
 
Top – Standards (Left peak: 3-aminoacetanilide; right peak 3-nitroacetanilide) Bottom – 10 min reaction 
 
3-aminoacetanilide MS/MS 
 
 
 
MS/MS of amino, hydroxylamine, and nitro components of 3-aminoacetanilide (M+H = 151,167,181 m/z respectively). Major 
fragmentation peak in amino and nitro compounds corresponds to a loss of the acetyl group in LC-MS. Hydroxylamine major 
peak corresponds to loss of oxygen. 4-aminoacetophenone UV  
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Figure 2.8 continued 
 
B) 4-aminoacetophenone UV trace 
 
Top – Standards (Left peak: 4-aminoacetophenone; right peak 4-nitroacetophenone). Bottom – 105 s reaction 
 
4-aminoacetophenone MS/MS 
 
 
MS/MS of 4-aminoacetophenone and its hydroxylamine product (M+H = 136,152, respectively). Peak at 94 m/z for the 
amino compound corresponds to formation of aniline by neutral loss of acetyl group. A similar m/z loss is seen in the 
hydroxylamine for the 110 m/z peak.  
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Figure 2.8 continued 
 
C) 4-amino 2-chlorobenzoic acid  UV trace 
 
Blue – 4-amino and 4-nitro 2-chlorobenzoic acid standards.   
Red – Reaction after 15 seconds with 10 µM enzyme 
Purple – Reaction after 1 min 15 seconds with 10 µM enzyme. 
 
4-amino 2-chlorobenzoic acid MS/MS 
 
 
MS/MS of 4-amino 2-chlorobenzoic acid and its hydroxylamine product (M+H = 154,170 m/z respectively) corresponding to 
loss of a hydroxyl group from the carboxylate. The M+2 peak is due to the isotope distribution of the chlorine atom.  
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In a few cases, there have been discrepancies between our work and literature regarding in the 
activity of AurF towards certain compounds. Compounds 16 and 17 have been shown by our work to be 
turned over by in vitro AurF (Figure 2.7), while oxidation of compounds 19, 22 and 25 could not be 
detected, but have previously been reported.10,17 As 16 and 17 share similar structural features (para-
oriented hydrogen bond acceptor) and comparable size with the native substrate, it would be unusual 
that they would not be transformed into nitro products by AurF, and we are able to detect at least the 
hydroxylamine intermediate on LC-MS. Although compound 22 is structurally and sterically quite similar 
to the tested compounds, the amidine group in this compound is positively charged, which may cause 
disfavorable electrostatic interactions with similarly charged residues R96 and R302. Therefore, it is 
surprising that LC-MS results from other groups have shown that it can be turned over by wildtype AurF. 
However, the nitro compound of 22 was only detected after reaction for 24 hours with H2O2, prolonged 
conditions which we could not achieve using the PMS/NADH reaction system.5  From literature, 
compound 25 has been reported to be slowly converted to its nitro product in whole-cell studies, but we 
could not definitively detect any turnover on HPLC.30 The activity of AurF in vivo for some m-substituted 
substrates was also determined (Figure 2.9). The partial conversion of MABA (29) to MNBA could be 
observed on HPLC in an overnight incubation, collaborating results from the in vitro assay. 1,3 
diaminobenzene  (28) depletion was observed under similar conditions, but we could not definitively 
confirm the production of either mono or di-nitro compounds. However, AurF-containing cells turned 
the media from clear to brown overnight, while the media did not change color in the control cells, 
indicating a reaction specifically catalyzed by AurF involving 28. In vivo reactions seemed to be more 
sensitive than in vitro assays due to longer reaction conditions and large total amounts of AurF, but 
overall activity may be complicated by the permeability of the substrates through the cell membrane.  
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Figure 2.9 . In vivo assays using MABA (29) and 1,3 diaminobenzene (28) as substrates.  
 
A) Top: Standards for MABA (blue) and MNBA (red). In vivo depletion of MABA for the AurF-containing BL21 cells (Middle) 
and BL21 cells carrying empty plasmid (Bottom). Blue corresponds to a 0 hour timepoint, while Red corresponds to the 
sample after overnight incubation. In all cases the wavelength used for measurement is 240 nm.  
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Figure 2.9 continued 
 
B) Top: Standards for 1,3 phenylene diamine (blue), 3-nitroaniline (red) and 1,3 dinitrobenzene (green). In vivo depletion of 
1,3 phenylene diamine for the AurF-containing BL21 cells (middle) and BL21 cells carrying empty plasmid (bottom). Blue 
corresponds to a 0 hour timepoint, while Red corresponds to the sample after overnight incubation. The AurF-expressing 1,3 
phenylene diamine media turned brown after overnight incubation, while the same media for the negative control remained 
white 
 
 
 
 
 
  
min0 5 10 15 20 25
mAU
-200
0
200
400
600
800
1000
1200
1400
 MWD1 D, Sig=240,8 Ref=off (LUIGI-ION-PAIR\04-30-11000004.D)
 MWD1 D, Sig=240,8 Ref=off (LUIGI-ION-PAIR\04-30-11000005.D)
 MWD1 D, Sig=240,8 Ref=off (LUIGI-ION-PAIR\04-30-11000006.D)
min0 5 10 15 20 25
mAU
0
500
1000
1500
2000
 MWD1 D, Sig=240,8 Ref=off (LUIGI-ION-PAIR\04-30-11000011.D)
 MWD1 D, Sig=240,8 Ref=off (LUIGI-ION-PAIR\04-30-11000037.D)
min0 5 10 15 20 25
Norm.
0
500
1000
1500
2000
 MWD1 D, Sig=240,8 Ref=off (LUIGI-ION-PAIR\04-30-11000012.D)
 MWD1 D, Sig=240,8 Ref=off (LUIGI-ION-PAIR\04-30-11000038.D)
 
 
30 
 
2.6. Kinetic Parameters of Alternate Substrates and Mutants  
Several substrates and mutants were considered for further analysis and characterization to 
further understand the substrate specificity and mechanism of AurF. Aside from the native substrate, 
three other compounds were chosen for kinetic analysis; 4-amino 2-chloro benzoic acid (3), 4-amino 
tetrafluorobenzoic acid (12), and 4-amino acetophenone (17). In all cases, the largest contributor to the 
lower activity compared to the native substrate is the much increased Km , since only a 40-60% decrease 
in kcat is observed (Table 2.2). Unusually, this drop in kcat is similar in magnitude for all substrates and 
mutants tested, suggesting some sort of baseline conversion rate for the substrates tested, which is 
enhanced when the native substrate and enzyme are used. For compound 3, the bulk of the chloro 
substituent can be accommodated by the entry pocket in the active site, and favorable interactions with 
the carboxylate recognizing residues are maintained (Figure 2.6D). This causes relatively small changes 
in the Km and kcat values compared to the native substrate, which is supported by the high activity seen 
towards 2’ substituted compounds (Figure 2.7A). Compounds 12 and 17 are isosteres of 1 and show very 
similar kinetic parameters to each other, however the basis for their kinetic parameters stem from 
different sources. The substitution of the hydroxyl group in 1 to a methyl group in 17 increases the Km by 
ten-fold, indicating that hydrogen bonding plays a major role in the stabilization and binding of the 
substrate to the active site pocket. Electrostatics of the active site also plays a large role in substrate 
binding, as evidenced by compound 12. In spite of the near-identical sterics of 1 and 12, the Km values 
for 12 are perturbed significantly, due to the reversal of polarity of the aromatic ring by fluorine 
substituents. However, the value for kcat for 12 and 17 are almost identical, indicating that electrostatic 
effects do not strongly affect the rate of catalysis.  
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Table 2.2: Kinetic parameters of wildtype AurF with selected substrates, and kinetic parameters of 
selected AurF mutants with PABA. 
 PABA (1) 
4-amino 2-
chlorobenzoic 
acid (3) 
4-amino 2,3,5,6- 
tetrafluorobenzoic 
acid (10) 
4-amino 
acetophenone 
(15) 
Mutant 
Y93A 
Mutant 
V97A 
Mutant 
T100A 
Km (µM) 14.7 ± 1.1 27.1 ± 6.8 137.1 ± 14.0 214.8 ± 26.5 
149.2 ± 
26.0 14.9 ± 7.4 24.6 ± 4.3 
kcat (min
-1
) 97.4 ± 11.1 38.5 ± 0.8 42.2 ± 2.3 46.1 ± 1.2 55.4 ± 5.3 25.4 ± 1.4 47.1 ± 6.4 
kcat/Km 
(µM
-1
 min
-1
) 6.6 ± 0.8 1.41 ± 0.35 0.147 ± 0.034 0.215 ± 0.027 
0.371 ± 
0.074 
0.836 ± 
0.420 
1.93 ± 
0.43 
A few AurF mutants were also selected for kinetic characterization. The high Km for Y93A indicates a 
decreased affinity towards PABA, consistent with the role of this residue in providing hydrogen bonds to 
the carboxy group. Although not directly comparable, this result is somewhat consistent with data from 
compound 17; the removal of a hydrogen-bonding hydroxyl group in both cases causes large changes for 
Km and kcat. In the case of V97A and T100A, the major change in activity stems from a change in kcat.  As 
these residues lie near the aromatic ring of PABA in the active site, these residues were expected to 
show a significant change in Km upon mutation to alanine due to the larger active site; however this 
change was not seen. It is unlikely that these particular residues participate in the actual mechanism of 
AurF, as V97 and T100 are far away from the closest metal. It has been suggested that conformational 
changes in the diiron cluster and possibly the active site may occur during the cycling of Fe2
II/II to 
(peroxo) Fe2
III/III, and if so, mutations of these residues may perturb the kinetics of AurF as these 
conformational changes occur.8  
2.7. Electron Transport Mechanisms 
A recent report has shown that that the AurF electron transfer pathway resembles the one from the 
ribonucleotide-reductase pathway, using native ferredoxin-type enzymes as electron mediators.29 We 
previously used phenazine methosulfate (PMS) and NADH to reconstitute the activity of AurF, and we 
wanted to see whether PMS/NADH also uses the same electron-transfer pathway as the ferredoxin-
based method. Incidentally, the PMS/NADH system has also been reported to allow a structurally similar 
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non-heme diiron enzyme to turnover substrates faster than even ferredoxin-based methods.31 To that 
end, we tested a few different mutants (R38A/G, W35A/F) based on docking studies of AurF with 
ferredoxin. Out of the mutants tested, only W35F was soluble, and was assayed using both 
ferredoxin/ferredoxin-NADP reductase and PMS/NADH. The W35F mutant has previously been reported 
to be inactive in vivo due to disruption of the ferredoxin-AurF electron-transfer pathway, but active in 
vitro via a peroxide-shunt mechanism.29 No activity was seen using the ferredoxin-based system, but 
with the PMS/NADH system, activity comparable to the native enzyme was seen (Figure 2.3C). This 
suggests that the PMS/NADH system reconstitutes the enzyme not through the complete ferredoxin 
pathway, either bypassing W35, or through some different mechanism.  
Table 2.3: Product Distribution of AurF using different reduction mechanisms  
 PABA (uM) PHABA (uM) PNBA (uM) 
Ferredoxin (5 µM AurF) 191.0 ± 4.7 36.9 ±0.5 6.8 ±1.6 
PMS/NADH (0.5 µM AurF) 214.0 ± 2.4 27.0 ±3.4 8.3 ±1.4 
H2O2 (20 µM AurF) 245.6 ± 2.6 0.2 ± 0.02 5.3 ±0.3 
Reaction conditions were 105 second reactions using 250 µM of PABA at pH 5.5.  Reactions 
were performed in triplicate, except for Ferredoxin PHABA, which was only quantified in 
duplicate due to coelution issues.  
 
Although the PMS/NADH system may not proceed through the native electron transfer pathways, 
the product distribution of AurF using this system is similar to the native electron transfer pathways in 
vitro, while the peroxide shunt mechanism provides a different product distribution. Accumulation of 
the hydroxylamine intermediate is observed in vivo and the in vitro ferredoxin/NADPH-reductase and 
PMS/NADH systems, while the primary product of the peroxide shunt is the final nitro product. (Table 
2.3 and Figure 2.10). It has previously been observed that in vitro, the peroxide-shunt mechanism 
produces slightly more of the nitro product than the hydroxylamine intermediate, while an in vivo 
experiment showed that the PHABA accumulates in greater than 12-fold excess compared to the nitro 
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product.11 It may be the case that in the peroxide shunt mechanism, the initial conversion of PABA to 
PHABA is a slow step; while in the other systems tested, the conversion of PHABA to PNBA is rate 
limiting. This would explain the differences in product distribution for the peroxide shunt and the other 
systems. Analogous to mechanisms found in other diiron enzymes, the peroxide shunt mechanism relies 
on the formation of a µ-(peroxo)diferric intermediate from a µ-(oxo)diferric state, bypassing the 
diferrous state (Figure 2.3C). 23,24,32 If the rate of µ-(peroxo)Fe2
III/III generation is much slower through the 
peroxide shunt mechanism (Step B in Figure 2C) than the Ar-NHOH → Ar-NO2 conversion (Step C), then 
whatever hydroxylamine is generated is quickly converted to the nitro compound. Li et al. have shown 
that conversion of PHABA to PNBA only requires the addition of oxygen to AurF, and does not require 
the input of electrons to effect the reaction. However, if step A (the reaction pathway used by 
ferredoxin and presumably PMS/NADH) is faster or goes at the same rate as step C, the accumulation of 
the hydroxylamine will occur. It is unclear why the peroxide shunt is slower in AurF, but similar results 
from T4MOH suggest H2O2 must lose its hydrogens before binding to the diiron center, or that binding of 
the peroxide distorts the active site and slows the oxygenation reaction.24 
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Figure 2.10. Comparison of in vivo and in vitro (Ferredoxin/Ferredoxin-NADPH, PMS/NADH, or Hydrogen Peroxide) assays 
using PABA (1) as a substrate. In vivo trials used OD 10 cells and 1 mM of substrate, while in vitro trials used conditions 
seen in the methods section. 
 
In vivo - E. coli BL21 (DE3) 1 hr (1 mM, 25 µL injection) 
 
 
In vitro - Ferredoxin pH  5.5 – 315 seconds  
 
 
In vitro - Ferredoxin pH 7.5 – 315 seconds 
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Figure 2.10 continued 
 
 
In vitro - PMS/NADH pH 5.5 – 315 seconds 
 
 
In vitro - H2O2 pH 5.5 – 315 seconds 
 
 
In vitro - H2O2 pH 5.5 – Unquenched (~Overnight) 
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2.8. Development of an In Vivo Assay for Directed Evolution 
Although AurF has been seen to have some promiscuity in the substrates it accepts, modifying its 
substrate specificity is of significant interest. Previous attempts to modify its substrate specificity were 
unsuccessful due to both a lack of a confirmatory in vitro assay, and a non-sensitive screening method. 13 
Based on previous work, the ideal method of AurF screening would be to quantify the amount of 
product present after several hours of incubation, and correlate that activity to a given mutation. 
Although several methods have been utilized by a previous member in lab, screening methods suffered 
from a lack of sensitivity and generalizability.13 To circumvent these issues, a method utilizing 
diazotization-coupling of the arylamine precursor was developed.33 Diazotization has been used for 
several decades as a method to detect either anilines or nitrites, with considerable sensitivity and 
reproducibility. This method is used industrially to create dyes and color compounds, as a variety of 
shades can be made by varying the composition of the diazotized amine and the coupling reagent.   
Diazotization relies on the formation of a diazonium compound (Figure 2.11A) from an arylamine, 
using sodium nitrite and a bronsted acid. This reactive compound is then coupled to a phenolic 
compound in order to generate an azo dye, which can be easily quantified by absorbance measurements 
or by visual inspection. Nitroaromatic compounds do not react under the diazotization conditions, and 
the intermediates of the reaction (hydroxlamines and nitroso compounds) do not interfere as well.  
Although the diazotization reaction reacts with all free amines, the stability of an alkyl diazo is much less 
than that of an aromatic amine, and is quickly reacted away by solvent. Additionally, the color formation 
only happens with the coupling of phenolic compounds to arylamines, increasing its accuracy. As there 
are only a few arylamines (PABA, nucleotides) in high concentration in the cells, the reaction is fairly 
specific. Color formation is fast, and the generated dyes are stable for days at room temperature. This 
method has the disadvantage of being somewhat carcinogenic; formation of nitrogen radicals and nitric 
oxide upon addition of acid to nitrite is a toxic prerequisite step in preparing the diazo intermediate. 
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Additionally, the coupling reaction requires several sequential time-sensitive steps, increasing the labor 
of the screening method. However, the advantages of the diazotization-coupling approach outweigh 
many of the disadvantages present in the assay, as it is the only one with the precision, stability and 
sensitivity required for screening.   
Previously in our lab, diazotization was tested and rejected as a screening method for AurF. This was 
due to the use of thiamine as a coupling reagent, which gave a relatively weak signal, and the low 
sensitivity and dynamic range of this method.13,34 However, improvements such as the use of 
ammonium sulfamate to destroy any remaining nitric acid in solution, as well as using  N-(1-
Naphthyl)ethylenediamine dihydrochloride (Bratton-Marshall Reagent) as a coupling reagent increase 
the sensitivity of the assay to micromolar changes (Figure 2.11A).33 The proposed screening method is 
illustrated in Figure 2.11B. A plasmid library containing mutants of Aurf (generated by saturation 
mutagenesis or error-prone PCR) is transformed into BL21 (DE3) cells, colonies are picked, and later 
regrown on a master 96 well plate. This plate is replicated depending on how many substrates  are to be 
tested. For each daughter plate, the cells are regrown and induced with IPTG overnight. The cell density 
is then measured, and then cells are pelleted by centrifugation and resuspended in AurF in-vivo assay 
buffer containing 200 µM of the substrate of interest.  The cells are allowed to consume the substrate 
for several hours, after which, 20-50 µL of the sample is transferred to a new 96-well plate and 
diazotized.  
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Figure 2.11:  A) Mechanism of diazotization reactions used in the Zhao lab for product detection. B) Screening method for 
detection of improved AurF mutants.  
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Figure 2.12. Response of several compounds of interest to the diazotization method.  All compounds with a free amine 
showed linear response to the coupling, with the exception of diamine compound G. 
 
To validate the screening assay, several substrates were tested for their performance in the 
diazotization procedure. As seen in Figure 2.12, diazotization of several arylamines could be visually 
distinguished even at low concentrations (20 uM), with a linear standard curve from 0-200 µM. 
Additionally, nitroaromatic products of the reactions did not produce any color change. The only 
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exception to this assay was the compounds  p-phenylene diamine  and its derivatives; no reaction to the 
diazotization was observed for either the dinitro or diamino compound, but a normal reaction was 
observed for the p-nitrophenylamine intermediate.  Even under these results, diazotization-coupling 
could provide a robust method of quantifying substrate depletion. The variation in response between 
identical wells was approximately 5-10%, making it reasonable for assay conditions.   
Optimum conditions were then established for the assay. As cells grown on 96-well plates do 
not grow to high densities, the effect of cell concentration was tested to determine the depletion rate of 
PABA as a baseline best-case scenario (Figure 2.13A). It was observed for flask-grown cells plated on 96-
well microplates, that having a higher OD600 during the assay increased the depletion of the substrate, 
with the best performance seen between OD 2-4. No-cell controls and empty pTrc99a BL21 cells (OD 4) 
did not show significant decreases in PABA concentrations, indicating the specificity of the assay 
towards AurF activity. The well-to well variation for flask-grown cells was approximately 5%, indicating 
the robustness of the detection method itself, however the cells grown on plates had significant 
variations in OD600 and were difficult to control. It was noted that the most difficult part of the assay was 
the cell growth, as in some cases cells did not grow well under the small volumes and limited aeration 
conditions found in microplates. Additional issues such as shaking and moisture control also were 
factors that could have influenced the uniformity of cell growth. In future experiments, the use of deep-
well plates would be an easier method to perform the assay; the larger culture volume would provide 
greater cell density upon centrifugation, and the bigger wells would prevent spillage and cross-
contamination between wells.  
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Figure 2.13 A) Response of PABA diazotization for several different cell concentrations at various timepoints. B) Activity of 
various AurF mutants in vivo using the diazotization screening method. 
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To verify the screening method further, AurF mutants with known activity were tested with the 
diazotization method (Figure 2.13B). Cells containing the wildtype AurF, an empty pTrc99a vector and 
known mutants Y93A, R96A, N200A, L203A were subjected to the same screening method. It was found 
that the in vitro activities of the mutants do not correspond to the screening method activity. This was 
attributed to the solubility of the different enzymes; significant changes in solubility were observed for 
the alanine mutants used, which influence their activity in vivo, but are invisible in vitro from soluble 
purified protein.  To increase expression of these proteins, AurF was also cloned into pMal-c2x in order 
to create a maltose-binding protein – AurF fusion protein. Although the wildtype protein showed 
identical activity to the MBP-tagged one in vitro, the results from the screening assay were inconclusive, 
and repeats have yet to be performed.   
As a final test of the AurF screening method, a series of single-site saturation mutagenesis 
libraries which modify the residues Y93, R96 and T100 were tested on MABA (29) , while Y93 alone was 
tested on 4-aminophenylalanine (25) as well .  As shown earlier, MABA was chosen for to demonstrate 
changing the regiospecificity of AurF, as the wildtype has some slight activity with this substrate. 
Additionally, MABA is a good intermediate evolutionary step in evolving for trinitrobenzene compounds. 
AurF has no activity towards 4-aminophenylalanine, but the compound can be biosynthesized, and has 
potential as an unnatural amino acid. While no mutants were found to have increased activity towards 
4-aminophenylalanine, a mutant Y93L was found to have 8% more activity than the wildtype towards 
MABA in vivo after reconfirmation. However, in vitro reconfirmation of this mutant was not performed 
due to the low increase in activity. Additionally, this particular mutant seems doubtful as a true mutant 
due to two reasons; the leucine amino acid is overrepresented in the NNK degenerate codon and is 
expected to be found in 3 / 20 colonies, but this mutant was found only once. Second, retesting the 
Y93X library failed to recover this particular mutant again. Thus some other reason is responsible for this 
anomalous result, possibly through host adaptation or cell density issues. Similar unknown failures in 
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engineering were also found in previous attempts to engineer AurF towards m-phenylenediamine , 
where results from the screening assay did not reflect large-scale in vivo results. 13 However, since only 
single sites were mutated instead of performing randomized mutagenesis, it is possible (although 
unlikely) that the sites chosen did not have significant influence in the substrate specificity. Similarily, 
later efforts to rationally design AurF to accept MABA did not show improvements in activity, indicating 
the difficulty in changing substrate specificity.  
Several issues can account for the failure of the screening method to detect positive hits from 
the saturation mutagenesis libraries. Although the screening assay works well according to control 
plates and reactions, problems with the large amount of handling and growth in the 96-well plate 
hampered the assay. Spillage and cell loss happened frequently with the manipulations necessary for 
the assay.  Additionally, comparisons between plates were difficult to follow; assays were self-consistent 
within an individual plate, but not within two different plates due to differences in growth rates and 
other factors. Automation of the assay by liquid handling systems could provide more reproducible 
results. Finally, the solubility of AurF is problematic; it was found that AurF has a propensity to form 
insoluble aggregates. Two approaches were used in literature to deal with this situation; fusion with 
MBP to increase solubility, and cloning into pTrc99a to provide a slower, weaker cell induction.11,13 
However, both approaches were tested, and no significant effects were observed in the screening 
method. Future work will attempt to deal with these issues, such as coexpressing the enzyme with 
chaperone proteins (GroEL/GroES), finding optimized growth conditions, and other solubility-increasing 
directed evolution methods.35,36 
2.9. Conclusions 
As the prototypical aromatic N-oxygenase, characterization of AurF’s mechanism and substrate 
specificity greatly widens the scope of this enzyme for possible engineering efforts. The unusual pH 
optimum and kinetic parameters of the enzyme indicates that the reaction relies heavily on a proton-
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transfer event, with kinetics, not binding being the limiting factor in the speed of the enzyme. Use of 
PMS/NADH as a reductant was found to be much superior to the native Ferredoxin/Reductase 
mechanisms, as well as the peroxide-based reductant. Based on the product distribution of AurF with 
these different reductants, the native reaction mechanisms can be explained as a two-step mechanism; 
an initial oxidation to produce the hydroxylamine intermediate, and a relatively slower step where the 
intermediate is oxidized to the nitro compound directly.  
AurF’s activity was probed in several ways. Characterization of AurF active-site mutants 
highlighted the purpose of several residues in substrate specificity and catalysis, however certain 
residues could not be easily explained. Substrate specificity was explored with a variety of compounds, 
and it was found that the enzyme is not as sensitive to substitutions at the 2’ and benzyllic positions. 
The main determinant of substrate acceptance was the sterics of the compound of interest, while a 
general baseline rate was observed for many of the substrates observed. Finally, a screening method 
was developed for directed evolution of arylamine N-oxygenases based on diazotization- coupling. This 
method proved to be robust and accurate. However,issues of handling and cell growth/protein 
expression variability hampered effective use of this assay. It is hoped that this characterization and 
assay development could further the engineering of AurF towards being used as a unique biocatalyst. 
2.10. Materials and Methods 
Cloning and Library Creation 
Restriction enzymes and polymerases used were from New England Biolabs. Plasmids containing 
AurF used in this study were identical to previous constructs in our lab 4,9. AurF point mutants and NNK 
codon saturation mutagenesis libraries were created by OE-PCR of primers containing the mutation of 
interest. These inserts were digested by HindIII and NcoI, ligated into a similarly digested pTrc99a 
plasmid, and electroporated into E. coli. Mutations were confirmed by sequencing. For MBP-based 
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constructs, AurF was subcloned from pTrc99a-AurF with EcoRI and HindIII as restriction sites, and ligated 
into similarly digested pMal-C2x for expression.  
Enzyme Purification 
E. coli BL21 (DE3) cells containing a pTrc99a-6His-AurF plasmid were grown at 37°C in Terrific 
Broth media and 100 ug/mL ampicillin. Cultures were induced at an OD600 of 0.6 with IPTG (final 
concentration 100 µM) and grown overnight at 25°C. Cells were centrifuged and resuspended in a pH 
7.4 buffer containing 20 mM NaH2PO4, 300 mM NaCl and 20 mM imidazole.  The cells were then lysed 
by sonication and protein purified via nickel affinity chromatography. Concentration and buffer 
exchange was performed by diafiltration with a 10kDa Amicon filter, and aliquots of the enzyme was 
stored at -80°C in a buffer containing 20 mM NaH2PO4 , 300 mM NaCl and 20% glycerol at pH 8.0. 
Enzyme concentration was determined by the BioRad Quickstart Bradford assay using bovine serum 
albumin as a standard. As a comparison, a  Pierce BCA Protein assay kit  was used with identical 
standards as the Bradford assay. Purification of ferredoxin and ferredoxin-NADP reductase was as 
previously reported.4 
Enzymatic Assay 
All reagents and compounds tested were obtained either from Sigma-Aldrich, TCI America, 
Matrix Scientific or Acros Organics. The pH assay was performed at 20°C with a final volume of 1 mL in 
the McIlvane buffer, using stock solutions of 40 mM NaH2PO4 and 20 mM citric acid (5X dilution of the 
originally listed stock solutions).37 The final assay mixture contained 0.5 to 2 µM AurF, 75 µM PMS, 750 
µM NADH and 100 µM of PABA in the McIlvane buffer. Addition of NADH initiated the reaction, with 
timepoints taken every 30 seconds. Reactions were quenched by addition of 20 µL of 5%(v/v) 
trifluoroacetic acid which gives a final pH of approximately 2. Depletion of substrate was used to 
quantify reaction rate. Specific activity of the enzyme was fitted to the following equation to find the 
pKa of the groups responsible for the pH dependence of the enzyme.38 
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For the rest of the assays, 20 mM MES buffer at pH 5.5 was used instead of the McIlvane buffer for 
the sake of convenience. NADH and PMS concentrations used were identical to the previous reactions. 
For kinetic determination of wildtype enzyme, 2.5-100 µM of PABA with 0.2 µM of enzyme was used, 
taking timepoints every 30 seconds. Kinetic parameters were obtained by fitting the Michaelis-Menten 
equation to the data using Origin 8 (OriginLab, Northampton, MA). For the alternate substrates assay, 2-
20 µM of AurF and 250 µM of substrate were used, with timepoints taken every 60 seconds for 3 
minutes. Mutant and alternate substrate kinetic characterization followed their respective timepoints, 
with substrate concentrations ranging from 15-400 µM. Negative controls containing no enzyme were 
also tested, with rates from non-enzymatic depletion of substrate subtracted from the assayed data. 
The peroxide-based assays were similar to the ones using the alternate substrates, using a final 
concentration of 20 µM enzyme and 1.2% H2O2 , and omitting the NADH and PMS. Assays using 
Ferredoxin/Ferredoxin-NADPH reductase used 5 µM AurF, 25 µM ferredoxin, 5 µM ferredoxin-NADPH 
reductase and 750 µM NADPH.  
In vivo AurF analysis 
Cells were grown and induced in a manner similar to the cells used in enzymatic purification of AurF. 
Cells were then centrifuged and resuspended in assay buffer to a final OD of 10.9 Substrate was added to 
a final concentration of 500 µM to 25 mL of the resuspended cells, and timepoints were taken after 
several hours. Cells containing a pTrc99a vector with no insert containing AurF were grown and tested in 
an identical way and served as a negative control.  
Screening Method 
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Mutagenic Libraries were electroporated into E. coli BL21 (DE3) cells, spread on LB+ampicillin plates 
and grown overnight at 37°C. Approximately 180 colonies were picked to be grown on two 96-well 
master plates containing 200 µL of LB+ampicilin. After overnight growth at 37°C, 10 µL of each well of 
the master plate was added to an assay plate containing 100 µL of LB+ampicillin media and grown for 3 
hours.  100 µL of LB+ampicillin containing IPTG was added to each well (final IPTG concentration 100 
µM) and allowed to further grow overnight at 25°C.  Cells were then pelleted and the media replaced by 
200 µL of assay buffer ( 200 µM of substrate, 8 g/L NaCl, 1 g/L KCl, 3 g/L glucose, 20 mM MOPS pH 7.2) 
and incubated at 30 C for 1-4 hours. 
For the diazotization-coupling reaction, whole-cell samples were centrifuged and 50 µL of 
supernatant was added to 25 µL of acetic acid in a well at room temperature. 50 µL of 1mg/mL NaNO2 
was added to diazotize the amines, and after 3 minutes, 50 µL of 5 mg/mL ammonium sulfamate was 
also added to the well. After a further 3 minute incubation, 50 µL of 1 mg/mL  1-(naphthyl) 
ethylenediamine dihydrochloride was added, which develops a pink-purple color within 10 minutes of 
incubation. Absorption of the diazotized substrate was then read at 550 nm.  Decreased absorbance 
compared to wildtype indicates increased turnover of substrate to a nitro product. The supernatant 
from the best 5 from each plate was analyzed by HPLC to confirm the production of a nitro compound. 
HPLC Analysis 
Analysis was performed on an Agilent 1100 HPLC with a Zorbax 
SB-C18 column (3.0µm x 200 mm). For kinetic characterization and 
mutant analysis the following method was used Solvent A: 1% acetic 
acid, Solvent B: Methanol. Flow rate 0.5 mL/min. PABA and PNBA were 
quantified at 290nm and 268 nm respectively. For LC-MS analysis, an Agilent 1100 LC-MS was used with 
identical conditions as above, but with a flow rate of 350 µL/min. APCI was used as an ionization source. 
For alternate substrates, a similar method was used; however ion-pairing reagents (2mM sodium 1-
Time 
(min) 
Buffer A Buffer B 
0 90% 10% 
7 90% 10% 
8.5 75% 25% 
10 25% 75% 
14 90% 10% 
23 90% 10% 
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heptane sulfonate) were added to each buffer, and a lower flow rate (0.4 mL/min) was used for good 
separation of the compounds. Compounds were detected using wavelengths of 240, 250, 268, 290, 320, 
and 380 nm and quantified via comparison to a standard curve.  
Docking / Modelling Studies 
Visualization and modelling studies were performed using VMD.39 For docking studies, PDB files 
with structure IDs 3CHH (AurF) and 1QT9 (Ferredoxin) were submitted to the ClusPro server 
(http://cluspro.bu.edu/), docked and scored.40  
Synthesis of PHABA 
 PHABA was synthesized according to previously described literature,8 except that 1.6 equivalents of 
Zn were used instead of 2 to prevent overreduction to PABA. PHABA was then purified via flash 
chromatography on silica with ethyl acetate as a solvent. The compound was verified by LC/MS and 
comparison to PHABA produced by AurF. 
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Chapter 3: Reconstitution of the Mangotoxin Gene Cluster 
3.1. Introduction 
 
The discovery of natural products from microorganisms is something of a challenge due to the varying 
requirements of the host. The common top-down paradigm of natural product discovery involves 
collecting significant amounts of a particular organism/biomass, performing chemical isolation of the 
compounds of interest, and later scaling up to increase production. However slow growth, unknown 
media and induction requirements, precursor availability and low productivity are challenges when 
working with native hosts.1,2 Frequently, significant and expensive optimization of culture conditions are 
required to produce significant amount of a compound, and in many cases, efforts to discover new 
compounds are for naught. With the growth of genome sequencing technologies and freely available 
gene databases, it has been found that even relatively well-characterized organisms contain cryptic 
biosynthetic clusters which have unknown gene functions and products. Thus, there is significant 
interest in a bottom-up approach; transferring gene pathways into tractable, well-characterized hosts 
such as Escherichia coli, Streptomyces lividans and Sacchromyces cerevesiae.  This has several 
advantages; well-characterized promoters and genetic backgrounds could provide increased production 
of compounds of interest, while careful host selection can provide easier separations and purifications 
of these compounds. Additionally, genetic alterations of biosynthesis proteins such as polyketide 
synthetases and non-ribosomal proteins and addition of alternative tailoring enzymes can alter the 
product of a particular gene cluster in defined ways, increasing the range of possible products that can 
be made.3,4  There are disadvantages, such as host incompatibility, lack of a resistance mechanism, 
protein solubility and precursor availability, but overall, this synthetic biology-based approach can 
leverage advances in genomics and pathway assembly to produce molecules and pathways never seen 
in nature.  
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Figure 3.1. Nitroaromatic compounds isolated from Pseudomonas species. 
 
The synthetic biology approach in reconstituting pathways also provides a way to study rare 
enzymatic reactions and natural products.  A few nitroaromatic compounds are known to be 
biosynthetically produced, and even less is known about their biosynthesis and enzymatic activities.5–7 
Thus, an initial thrust of this project was to identify gene clusters containing nitroaromatic compounds. 
As a good assay for AurF was established, and with further work with CmlI confirming the validity of the 
assay, it was thought to use AurF as a probe for clusters producing nitroaromatics.6,8 With the use of 
modern cloning methods such as DNA assembler and Gibson Assembly, manipulations of the gene 
cluster could be performed to find cryptic products.9,10 Thus, the reconstitution of a putative 
nitroaromatic cluster from Pseudomonas syringae was chosen as a demonstration of this approach. This 
approach is promising for several reasons. Pseudomonas species are known to be able to grow well on 
xenobiotic nitro compounds such as TNT, nitrobenzene and nitrotoluene.5 Several naturally nitro 
compounds have been isolated from a variety of Pseudomonas species with a variety of biological 
activities (Figure 3.1). Finally, it has been reported that nitroaromatic compounds function as 
chemoattractants for several Pseudomonas and Burkholderia species, indicating a biological role for 
these compounds.11,12 
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Figure 3.2. Organization of the Mgo operon and closely spaced genes. The operon in the dashed box indicates the main 
genes of study in this thesis. The dotted arrow indicates a gene present in several, but not all Pseudomonas species with 
the operon. 
 
The particular cluster of interest codes for a putative nitroaromatic compound known as 
Mangotoxin (Figure 3.2). The role of Mangotoxin is unclear due to several issues, but it is hypothesized 
to function as a signaling molecule. Initial work by Arrebola indicated that the Mangotoxin cluster (mgo) 
works as a virulence factor in Pseudomonas syringae, effecting chlorosis on tomato leaves. 13 From 
rescue assays, they identified the biochemical target of the Mangotoxin cluster as ornithine/arginine 
biosynthesis, as feeding ornithine rescued toxicity effects in E. coli. After significant effort, they were 
able to identify a peak corresponding to this toxicity, but  could not identify the compound responsible. 
14 However, later characterization of the Mangotoxin cluster indicated that a second cluster (mbo) was 
also involved with the Mangotoxin cluster’s activity, and could explain the lack of E. coli toxicity for 
extracts of certain P. syringae strains carrying the mgo operon.15 Separately, Vallet-Gelly et al. have 
demonstrated that an analogous mgo cluster in Pseudomonas entomophilla (the pvf cluster) encodes a 
signaling molecule which induces death in Drosophila melanogaster. 16 Lowered transcription levels of 
the GacS/GacA signaling pathways was observed upon disruption of the cluster, and through 
complementation studies, evidence points out to the product of the mgo cluster as a signaling molecule, 
rather than a virulence factor. Further work by the former group agreed with this assessment, indicating 
the possible induction of another gene cluster from the gene product of this cluster.17 As such, in this 
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report, Mangotoxin will refer to the putative product of the cluster, and not to any of its phenotypic 
effects.  Interestingly, a very strong inducer of the N-acylserine lactone system is a synthetic 
nitroaromatic lactone which inhibits the LuxR signaling of gram-negative Vibrio fischeri.18 As other gram-
negative bacteria use similar quorum-sensing mechanisms, Mangotoxin’s putative structure may be 
similar to these types of compounds (nitroaromatic lactone), giving some evidence to a possible 
mechanism.  
3.2. Bioinformatics Characterization of the Mangotoxin (mgo) Gene Cluster 
To discover natural product clusters producing nitroaromatic compounds, AurF was used as a probe 
sequence in sequence searches. This idea was validated by the identification of known N-oxygenases for 
the chloramphenicol and althiomycin biosynthetic clusters from bioinformatics searching.8,19 BLAST 
results of AurF showed the cluster with the most promise was the mgo cluster from several 
Pseudomonas syringae hosts, which produces the cryptic compound Mangotoxin. However, as the 
actual structure of Mangotoxin is unknown, the cluster itself has not been precisely delimited. According 
to Arrebola et al., the Mangotoxin gene cluster (mgo) is composed of 3 genes encoding an AurF-like 
protein, a non-ribosomal peptide synthase and a polyketide cyclase (Figure 3.2).14,17 These genes are 
expressed in an operon structure, with an additional gene thought to be a transposase coexpressed 
before the others. This motif is conserved in many other Pseudomonas and Burkholderia species, with 
known nitroaromatic compounds such as pyrrolnitrin produced in these strains. 20 Only the last 3 genes 
of this operon are required for observed activity, as shown by knockout experiments in literature.16,17 
Although the Mangotoxin cluster’s boundaries have not been fully established, understanding the 
putative product of this cluster requires analysis of each gene in the common operon. The mangotoxin 
NRPS gene MgoA encodes for a single adenylation and reductase domain as well as one 
phosphopantetheinylation site, indicating that the product is a single amino acid .21 Functionally, this is 
similar to the NRPS CmlP found in the Streptomyces venezuelae chloramphenicol biosynthesis cluster, 
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with the exception that there is no reductase domain in CmlP. Although only 33% homology exists 
between these proteins, they have similar sizes (1149 for MgoA vs 963) and the predicted substrate for 
their adenylation domains is phenylalanine.22 In the case of CmlP, it is known that the actual substrate is 
p-aminophenylalanine, and that several modifications of the substrate are performed as the substrate is 
attached to the NRPS.23 The AurF-like gene MgoC  shares only 39%  homology to AurF, but shares 
common structural features like the presence of a diiron binding site, and several conserved residues for 
N-oxygenation. According to studies done by Sazinsky et al., MgoC functions similarly to AurF, producing 
nitroaromatic compounds, with the greatest activity seen for 2-aminophenol derivatives.24 However, as 
NRPS-like enzymes require the presence of an amino acid for coupling, the simple aromatic compounds 
tested do not provide a method for interfacing with MgoA. Some limitations of the paper were the fact 
that they did not test aminophenylalanine as a substrate, and their assay used peroxide to reconstitute 
the enzyme, while in the case of AurF and CmlI, the best results were found for PMS/NADH as a 
reduction system. 6,8 
The two other genes in the mgo cluster are more difficult to understand. MgoB is ever-present in 
the Pseudomonas species, but its function is unknown. BLAST results show that the closest known 
function of this protein is as a transposase, which supports the findings of Arrebola et al. that only the 
last 3 genes in the operon are important in the synthesis of Mangotoxin.17The final gene MgoD serves as 
a putative polyketide cyclase or as an abscisic acid receptor, so its actual function is unknown. A similar 
protein in E. coli YdgA serves to control the swarming behavior of this microorganism, but the 
mechanism of this behavior is also unknown. Several other genes (ORF 5-8) close to the mgo cluster 
have been reported to have no effect when they are disrupted, but conclusive evidence has not been 
shown yet. 
 Knowing MgoC requires an arylamine substrate, and assuming the polyketide cyclase performs a 
lactonization reaction, the likely product of the cluster is a compound similar to Obafluorin from 
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Pseudomonas fluoresens (Figure 3.1), as it contains all these chemical motifs. From feeding studies, 
Obafluorin is derived from the condensation of p-aminophenylalanine and glycine, explaining the need 
for an NRPS, as well as providing a likely substrate for the Aurf-like gene. Additionally, the lactone 
present in Obafluorin could be obtained by reacting the product of the NRPS with the polyketide cyclase.  
However, the Mangotoxin operon itself may not be complete; several variants of the operon encode an 
additional cupin protein between MgoB and MgoC.  Additionally, there is no means to attach the glycine 
to the amino acid, as there is no additional condensation or adenylation domain in MgoA . Another set 
of candidate compounds for the cluster’s production are nitropapuline and methyl (2,5-dihydroxy-3-
nitrophenyl) acetate(Figure 3.1). Both are attractive due to the fact that they were originally obtained 
from P. syringae strains, functioning as phytotoxins and phytostimulants, respectively. 25,26 These 
compounds seem to also be derived from aminophenylalanine, and the presence of the hydroxyl group 
next to the nitro group coincides with the observations of Sazinsky et al. about preferred aminophenol 
substrates for the enzyme.24 However, there is no role for the polyketide cyclase gene, and genes for the 
methylation, deamination and hydroxylation of the compounds are missing. Thus, although possible 
products produced by the Mangotoxin cluster can be identified, several factors complicate unambiguous 
identification of the compound.  
3.3. Cloning of the Mangotoxin Gene Cluster 
A variety of cloning strategies were attempted to reconstruct the Mangotoxin cluster. The initial 
approach was to clone a large portion of the neighboring genes and first try to overexpress them in the 
native P. syringae host. It was assumed that cloning the genes into a multi-copy plasmid would drive the 
overexpression of the target genes. The boundaries of the gene cluster were initially unknown as well, 
thus this approach was a reasonable approach in forcing gene production. To this end, the DNA 
assembler method was used to generate two constructs.3 First, a plasmid (hereforth referred to as 
Mangotxin V1/Construct A) with approximately 15 kb of genomic DNA containing the putative 
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Mangotoxin genes was cloned and assembled via yeast-based homologous recombination. The 
backbone for this construct was cloned and designed from several other fragments; a yeast helper 
fragment cloned from pRS416 encoding with a CEN/ARS origin of replication and a URA3 gene for use as 
a marker for uracil auxotrophy, an E. coli helper fragment from pTrc99a encoding the ampicillin 
resistance and the BR322 origin of replication, and a Pseudomonas helper fragment from pUCP19 
containing an origin enabling replication in Pseudomonas species (Figure 3.3A).  The second construct to 
be made (named Master Helper Plasmid), used the same backbone fragments as the first construct, but 
had an additional LacI gene for repression of any lactose-inducible genes, as well as NotI and PacI 
restriction sites, which are cut only once on the plasmid, and will be relatively rare as restriction sites 
(Figure 3.3B). Thus, the Master Helper plasmid can be used as a shuttle vector for work in yeast, E. coli 
and Pseudomonas species, and its propagation in all three hosts was verified. In both cases, the DNA 
assembler method worked with high efficiencies to provide the correct construct. 
After the successful cloning of these constructs, the logical step was to put promoters in front of 
presumed gene clusters. After careful consideration, ORF 5-12 were recloned into operon-like 
structures.  As the DNA assembler method relies on homology to create correct constructs, the 
promoters used needed to be different from each other. As it is known that Lac-based promoters 
function both in E. coli and Pseudomonas species, the promoters pTrc and pTac were chosen to drive the 
expression of the genes (Figure 3.3C). However, multiple attempts to construct the refactored pathway 
failed, even after extensive troubleshooting. The reasons for the failure to construct the correctly 
assembled pathways could not be precisely determined; however, several possibilities such as the high 
homology between the pTrc and pTac promoters, the formation of a designed operon-like structure, the 
use of a large number of fragments, or problems with homology regions could in combination affect the 
efficiency of assembly.  
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Figure 3.3. Constructs used in this assay. Initial multi-copy overexpression plasmid A and master helper plasmid B were 
constructed via DNA assembler. Construct C with trc and tac promoters was designed, but could not be assembled. 
Construct D, E and F were constructed by Gibson Assembly, with construct D and F utilizing operons to express the mgo 
cluster. Construct E uses T7 promoters in front of each gene. 
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Upon the failure to make the correctly assembled constructs multiple times, alternative methods of 
gene assembly were attempted. Several genes were individually cloned into pET28a and pTrc99a using 
restriction/ligation to create the constructs. This provided the advantage of incorporating promoters 
and terminators which could drive genes independently. One-pot Golden Gate assembly was attempted, 
but with only partial success.27 Finally, Gibson assembly was used to construct several different versions 
of the constructs of interest.9 Through this method, T7 and Trc-promoters were used to create 
constructs in either operon or individual-gene forms respectively in either pET28 or pTrc99a-based 
constructs (Figure 3.3D and F).  In another construct, T7 promoters were placed in front of each gene in 
the cluster via Gibson assembly (Figure 3.3E). Using those same primers, single-gene deletions were 
constructed using the same strategies, but only the MgoA deletion (Del 11) was successfully confirmed.   
3.4. Expression of the Mangotoxin Gene Cluster 
Attempts were made to heterologously express the Mangotoxin cluster in E. coli. Single-gene 
constructs cloned into pET28a were seen to express in good amounts in E. coli, with the exception of the 
MgoA gene having much less expression than the others (Figure 3.4A).  This was not unexpected, as the 
gene was much larger than the other proteins in the cluster, and there may be a significant metabolic 
burden associated with the NRPS production. All genes were seen to express in E. coli when the 
heterologous T7 promoter was used in the operon, indicating the mRNA is expressed completely, with 
no premature truncations. Additionally, the conserved operon structure showed that the Pseudomonas 
ribosome-binding sites are compatible with the E. coli translation machinery. These results were very 
promising, as they showed that E. coli could possibly operate as a good heterologous host for 
production of the Mangotoxin gene product. However, the limitation of an operon-based construct is 
the possible polar effect of the gene expression; later genes may have lower expression than initial 
genes. This prompted the construction of a plasmid placing T7 promoters in front of every gene for 
uniform expression (Figure 3.3E).   
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A) 
 
B) 
 
C) 
 
   
Figure 3.4: Expression of the Mangotoxin genes. A) Expression of each gene cloned into pET28 in BL21 (DE3) cells. B) 
Expression of the operon based constructs. Left to right: Empty Plasmid, Construct F, and pET28a-T7 GoldenGate/Gibson 
operon. Arrows indicate the overexpressed genes.  C) Expression of single-plasmid T7-promoter genes. Left to right: 
Negative Control, MgoA deletion, Construct E.  
 
In the case where the T7 promoter drove the complete operon, the plasmid was found to be 
stably maintained, with visible expression of all four proteins. However, cloning the T7 promoter before 
every gene caused plasmid instability in certain strains. RecA deficient strains (DH5α or Top10) were 
seen to maintain the plasmid well; however transformation of the plasmid into expression strains BL21 
and its derivatives (BAP1) showed that recombination occurred, with the elimination of portions of the 
plasmid (Figure 3.5). Thus, correct protein expression was not observed in construct E, while a similar 
construct Del 11 (an identical plasmid except for MgoA deleted)  at least showed expression of MgoD 
(Figure 3.4C). Similar results were seen in several deletion plasmids with the repeated T7 promoter.  The 
cause of this was not conclusively determined, but there were several possibilities for this event. One 
possible reason is the presence of several identical promoter regions, which are approximately 70 bp in 
length. Since recombination is favored at highly homologous regions, identical stretches of DNA could 
cause resection and modification of the plasmid.28 Contrary to this suggestion is previous precedent in 
literature; it has been shown in the case of the heterologous expression of FR-900098 that multiple T7 
promoters can be maintained in BL21 (DE3), and several other groups have created constructs 
containing multiples of the same promoter on a single plasmid.29 Another possibility for the gene 
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instability is the possible toxicity of the Mangotoxin product. This is unlikely for a few reasons, such as 
the lack of an inducer for the T7 promoter, as well as the putative role of the gene product as a signaling 
molecule. However, since there is no T7 RNA polymerase in the cloning strains used, and the possibility 
of leaky expression of the T7 promoter in BL21 (DE3) strains, this possibility cannot be discounted. To 
avoid this problem in the future, each gene is planned to be cloned into Duet vectors and coexpressed 
from separate plasmids simultaneously. The Duet vectors allow expression of two genes under T7 
promoters in each plasmid, and since these vectors have different resistance markers and replication 
origins, the Mangotoxin genes may possibly be expressed. Finally, a RecA-deficient host cell expressing 
both the T7 RNA polymerase and the sfp pptase  could be used in the future to retain plasmid stability 
and expressivity. A possible strain to be used is the NovaBlue DE3 strain, which is designed for 
expression of toxic genes under unstable plasmids. The pptase could then be supplied on the host 
plasmid itself.  
A) 
 
B) 
 
  
Figure 3.5: Analysis of recombination events for plasmids with multiple T7 promoters. A) Digestion of putative Construct E 
using EcoRV. #5 and #6 correspond to correctly assembled plasmids. These plasmids were obtained by Gibson Assembly 
and electroporation into Top10 cells. B) Plasmids #5 and #6 transformed into BAP1, plasmid extracted and redigested with 
EcoRV. The 1.2 kb band was lost in the resulting plasmid, and a ~500bp deletion was observed from the 3kb band. 
 
The question of expression of the Mangotoxin genes in E. coli had been answered, however, 
whether the native host expresses these genes was also investigated. RNA from 3-day old cultures was 
isolated from the native P. syringae v. tomato hosts, and qPCR was performed to detect the expression. 
Genes from ORF 5-ORF 12 (Figure 3.2) were tested, and the housekeeping gyrA gene was used as an 
internal standard. However, the results from this assay were mixed. Most genes were transcribed at the 
3-day timepoint, but MgoC and MgoA showed no amplification from either genomic DNA or cDNA, 
#5   #6 
5-A    5-B     6-A    6-B 
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indicating bad primers. Even worse, the internal standard also did not amplify. Thus, only a binary 
analysis (gene expressed or not) was possible. However, these results were still useful; since the mgo 
genes lie in an operon and transcription of the first and last genes MgoB and MgoD was detected, it can 
be assumed that the intermediate genes MgoC and MgoA were also expressed. This is supported by 
work by Arrebola et al. who by RT-PCR showed the mgo genes are expressed in an operon. Thus, it has 
been shown that the operon itself is expressed natively, and the putative gene product is produced 
naturally.  
3.5. Detection of Products and Intermediates 
As it was proven that the genes in the Mangotoxin cluster could be expressed in E. coli and that the 
operon itself is expressed natively in the Pseudomonas host, the detection of the putative gene product 
could be performed in two parallel approaches; heterologous reconstitution of the cluster, and product 
extraction from the native host. Both approaches were tested in this project, through feeding assays and 
media extraction protocols. Additionally, in vivo reconstitution of MgoC was also tested to narrow down 
the possible precursors of the cluster.  
As the precursors for Mangotoxin are unknown, a look into possible products from this cluster is 
warranted.  Nitroaromatic compounds isolated from Pseudomonas species suggest that the compound 
is based on aminophenylalanine derivatives.25,26  Obafluorin has been shown to be produced from p-
aminophenylalanine and glycine, indicating that Pseudomonas species produces this arylamine. 
However, E. coli does not natively produce aminophenylalanine, and although it is possible to produce 
this compound heterologously, the construction of that particular pathway in the support pathway did 
not succeed. Since aminophenylalanine biosynthesis branches off the shikimate/chorismate biosynthesis 
pathways, a BLAST search of the signature p-aminophenylalanine biosynthesis genes was performed. 
The CmlD gene from Streptomyces venezuelae encoding for a chorismate mutase was used as a 
template for the search, as it is the committed step in synthesizing p-aminophenylalanine from 4-
 
 
63 
 
amino4-deoxychorismate.  Similar genes with 38% identity were found in several P. syringae species, 
indicating the possibility of synthesizing a similar arylamine derivative.  However, this number is very 
low. Aside from the shikimate pathways, hydroxylated aminobenzoates have been obtained from TCA 
cycle derivatives, raising the possibility that this is the possible precursor of the compound.30 If so, it 
remains to be understood how this second pathway could be incorporated to make a phenylalanine 
derivative.  
 
Figure 3.6: Feeding studies with the pTrc99a-Gibson Construct (D) in BL21 (DE3) cells.  
 
 A) Feeding with 4-aminophenylalanine . Top: Feeding of the construct with 4-aminophenylalanine. Encircled peaks indicate 
unique compounds produced only in the Gibson-assembled construct. Middle: Feeding of the empty plasmid negative 
control with 4-aminophenylalanine. Bottom: Identification of the nitrophenylalanine product by comparison of retention times.  
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Figure 3.6. continued 
 
B) Feeding with PABA. Top: Feeding of the construct with PABA. Encircled peaks indicate the hydroxylamine (left) and nitro 
(right) compounds produced only in the Gibson-assembled construct. Bottom: Feeding of the empty plasmid negative control 
with PABA.  
 
 
 
 
 
 
An initial feeding assay in E. coli using several aromatic amines was performed to check the 
substrate specificity of the Mangotoxin cluster. The compounds 4-aminobenzyl alcohol, 4-
aminophenylalalnine, 4-aminosalicylic acid and 4-aminobenzoic acid (PABA) were used as feed 
compounds. In the case of PABA and 4-aminophenylalanine, putative hydroxylamine and nitro 
compounds were detected, and with the other compounds, new peaks were observed via HPLC (Figure 
3.6). However, as the strain used was a BL21 (DE3) strain with no phosphopantetheine transferase gene, 
it is believed that the MgoA remained in its apo-form, and thus no products from the NRPS were 
expected. Thus, the new peaks are probably from the MgoBCD genes. Future work for this construct 
involves repeating this feeding assay with the BAP1 strain to have a functional pptase.  
The feeding assay confirmed the production of p-hydroxylaminophenylalanine fed from the 
amino precursor. More tellingly, p-nitrophenylalanine was detected as well.  This indicates that the 
substrate specificity of this cluster is unlike AurF (which uses p-aminobenzoic acid as a precursor) and 
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more like CmlI (which uses amino-chloramphenicol as a substrate and also contains an NRPS in the gene 
cluster). Definitive detection of the hydroxylamine and nitro derivatives of PABA indicated the generality 
of this substrate for N-oxygenases, as seen for several other arylamine oxygenases. 6,8,24,31 Additionally, 
the in vivo reconstitution of the N-oxygenase activity indicates that the ferredoxin-based electron 
transfer pathway in E. coli also works for MgoC. Thus, electron transfer mechanisms devised in AurF 
should be applicable to this analog.   
Based on these results, in vitro reconstitution of MgoC in the cluster was also attempted. In 
literature, this enzyme was reconstituted via a peroxide-based assay, with 2-aminophenol being the best 
substrate. However, our findings from AurF suggest that the PMS/NADH system is far superior to this 
method, and this was attempted. Six substrates (para, meta and ortho-aminobenzoic acids, P-
aminophenylalanine, p-aminolactic acid and 4-amino 3-hydroxybenzoic acid) were tested at two 
different pH levels (pH 5.5 and 7.5). However, no depletion was observed of the substrate for any of the 
compounds, even with 5 µM of enzyme. Work done by Sazinsky et al. showed that at least PABA is 
turned over by the enzyme in vitro, but in our case, no activity was observed when their method was 
attempted. This suggests that the particular purified protein was inactive, thus, the in vitro 
reconstitution of MgoC has not been performed. Further repurification and assaying will be performed 
to solve this issue.  
Product detection from the native P. syringae v. tomato host was also attempted. Since the 
Mangotoxin molecule is a small molecule which functions as a putative signaling molecule, the 
production of the compound in the native host may be vanishingly small. This is collaborated by studies 
with other Pseudomonas nitroaromatics, requiring growth of several liters of media to isolate low 
milligram amounts of the compound. 25,26,32 As it was assumed that the product was a nitroaromatic 
compound, the diazotization-coupling protocol established for AurF was tested to determine its 
applicability for product detection(Figure 3.7). Briefly, reduction of the nitroaromatic compound 
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produces an arylamine compound. Treatment of this compound with sodium nitrite and acid produces a 
diazonium compound, which then is coupled to an activated aromatic system (napthalenes or phenols) 
to form a strongly colored compound. The detection limits of this method are in the micromolar range, 
which was assumed to be sufficient for compound detection. This protocol was initially verified by 
testing P. syringae grown for 7 days in Wooley’s media according to the protocol by Evidente et al. 
25,33After acid extraction of 3 liters of media with ethyl acetate, the sample was concentrated and 100 µL 
was subjected to reduction by Zn/HCl and the resulting amine was detected by diazotization. Control 
samples of nitrophenylalalnine and the growth media were tested as well, and only significant color 
development was observed in the positive nitrophenylalanine control and a weak purple color for the 
organic extract (Figure 3.7B). Both the growth media and the no-diazotization negative controls showed 
little color change, indicating that some nitroaromatic compound was indeed reduced and detected by 
the diazotization protocol. Since the diazotized compound absorbs light at a relatively high wavelength, 
it can be detected on HPLC or TLC, with its mass determined by LC-MS. 
As the production of the compound was low, P. syringae was transformed with construct A 
(Figure 3.3A) to try to overexpress the compound by having multiple copies of the gene cluster present. 
This construct, and the native host were then grown for 5 days in M9, Wooley’s media and King’s Media 
B, and then extracted with ethyl acetate under acidic conditions. A parallel extraction step using 
Amberlite XAD resin was also attempted to gauge the effectiveness of the extraction method.  However, 
HPLC and LC-MS identification of the compound could not be established in any of the cases. Other 
nitroaromatic compounds such as nitropapuline were not detected via LC-MS, which could parallel the 
case seen for AurF, where spiked-in nitroaromatic standards could not be detected on LC-MS. The 
diazotization protocol was not performed at this point, so arylamine precursors were not detected. 
Compounding the difficulty was the fact that the only point of comparison was the native host itself; as 
no gene knockouts of the cluster were created at this point, the only way to find the compound of 
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interest would be the overexpression of the gene cluster in the plasmid-based construct compared to 
the wildtype. Some work was performed to try to delete the Mangotoxin cluster in the native host via 
RecET-based recombineering, but as of this date the work has not been concluded.34  
A final attempt to detect the compound in Pseudomonas media was attempted (Figure 3.7C and 
D). Both the native host and construct A containing cells were grown in King’s Media B for 3 days, and 
and extraction of the media with ethyl acetate was performed. An additional methanol extraction of 
pelleted cells was performed to extract metabolites locked intracellularly. From these, small portions 
were diazotized directly, or reduced first by Zn/HCl, and analyzed by HPLC. Upon visual analysis of this 
sample, it was found that the King’s Media B gave a weak background signal, while extraction of both 
the native cells and the construct A cells also gave a similar weak signal (Figure 3.7C). As the previously 
used Wooley’s media is a defined minimal media, the lack of a diazotizable compound in the media is to 
be expected, and since King’s Media B is a complex media, the presence of a diazotizable compound 
from either the yeast extract or the peptone base could explain the weak signal. A strong signal could be 
detected from the reduced and non-reduced wildtype media, and HPLC analysis confirmed that the 
source of this signal was from diazotized PABA, possibly from the media, but more likely to be produced 
intracellularly. An unknown diazotization product was also seen at low concentrations at 19 minutes, 
which could possibly be the Mangotoxin product. As the assay itself is very sensitive, the low area 
indicates the very small amount of this compound .Further work by HPLC and LC-MS will be performed 
to confirm the identity of the new peak.  Surprisingly, the diazotization protocol failed to detect any 
strong nitroaromatic signal from Construct A, which was supposed to overexpress the cluster itself.  The 
reason for this anomaly is unclear; however, the growth of this construct was somewhat worse than 
that of the wildtype (although the media was treated with Ampicillin to maintain the plasmid), and this 
may have caused a difference in cell growth and metabolite production compared to the control.  
Reconfirmation of the plasmid could not be performed via miniprep and digestion, due to the presence 
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of several other native plasmids in the P. syringae pv. tomato strain used.  Thus, although there are 
promising results in this assay, more work needs to be done to confirm the presence of a nitroaromatic 
compound. Additionally, large scale growth / feeding experiments may need to be performed to isolate 
enough compound for study.  
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B) 
 
C)
 
D)  
 
 
 
 
Figure 3.7: Diazotization method for detection of the putative Mangotoxin product.  
A) Schematic of the diazotization protocol used to detect Mangotoxin. 
B) Detection of the Mangotoxin compound from 3 L of Wooley’s media after reduction-diazotization.  
C) Diazotization results of the wildtype P. syringae and P. syringae carrying construct A. No significant difference was seen 
visually for samples which did and did not undergo reduction with Zn/HCl.  
D) HPLC profiles of the wildtype P. syringae media extract. Top: HPLC chromatogram at 290 nm. Blue indicates the sample 
without reduction/diazotization, while red indicates the same extract after diazotization. Middle: Detection at 550 nm of the 
same samples to detect diazotization products. Bottom: Diazotized media extract (Blue), and diazotized PABA (Red), 
indicating the compound responsible for the positive diazotization result is PABA. Encircled in red is a unique diazotized 
compound.  
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3.6. Synthesis of Compounds  
The nitro compounds produced by P. syringae share a motif where the nitro group is adjacent to a 
hydroxyl group (Figure 3.1). This is collaborated by literature results showing that 2-aminophenol is one 
of the best substrates for MgoC.24 Interestingly, this was thought to be unlikely, based on AurF substrate 
specificity studies, as 3’ substituted aminobenzoates showed no activity with AurF due to steric issues. 
Since this motif seems to be conserved, it may be that the substrate for the NRPS is a hydroxylated 
aminophenylalanine.  It was noted in literature that the positions for the hydroxyl and nitro moieties for 
nitropapuline were difficult to assign, and it is possible that they may be switched on the benzene ring. 
This would make the compound similar to the methyl (2,5-dihydroxy-3-nitrophenyl) acetate also isolated 
from the same organism (Figure 3.8) . 25,26 However, as there are no other oxygenase or P450 genes 
close to the cluster, the source of the biological hydroxylation is unknown. Thus, it was of interest to see 
whether these aminohydroxyphenylalanines (AHP) could be used as a substrate for in vivo and in vitro 
reactions.  
Chemical synthesis of these compounds involved several laborious and time-consuming steps. 35 
However, the main degradation products of pheomelanin, a compound derived from hair and 
melanocytes, were exactly the AHP compounds required. As seen in Figure 3.8, a semisynthetic method 
by Ito uses mushroom tyrosinase to first oxidize L-DOPA into dopaquinone. This compound then 
condenses with cysteine to prepare the pheomelanin pigment. Reduction and hydrolysis of pheomelanin 
produces the two isomers of AHP.36 Although the final yields for this process is low (~20 % according to 
literature), the synthesis is relatively benign and straightforward, with results obtained within a few 
days.  
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Figure 3.8: Aminohydroxyphenylalanines and their synthesis. A) Comparison of compounds isolated from P. syringae and 
AHPs synthesized. B) Synthetic scheme for synthesis of both AHP isomers. C) LC-MS analysis of synthesized AHP in 
positive and negative mode. UV and ion extraction indicated the presence of the compound.   
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According to the protocol used, a yield of ~ 75 mg was expected for the pheomelanin given the 
conditions we used for the synthesis. However, only 9 mg of product was obtained (12 % yield), 
indicating that significant room for optimization remains. LC-MS analysis of the product indicated that 
the synthesized compound was AHP, with some unknown byproducts (Figure 3.8C). As resolution of 
each isomer could not be achieved, it was unknown how much of each isomer was present in the 
sample, but as a compound 3-nitrotyrosine is commercially available and metal-mediated reduction of 
that compound is straightforward. Thus, a pure standard can be obtained for at least one of the AHP 
isomers. An initial feeding study was perfomed on this compound, however the previously mentioned 
plasmid stability issues were encountered, and thus compound turnover was not established. Further 
work such as scaling up the reaction to isolate more AHP is planned. After production of more of these 
compounds, more feeding and enzymatic assays will be performed to validate these compounds as 
substrates for the Mangotoxin gene cluster.  
3.7. Conclusions 
As demonstrated in this work, progress has been made towards the reconstitution and discovery of 
the Mangotoxin gene product.  Successful cloning of several constructs for expression in E. coli and 
Pseudomonas were constructed, and heterologous expression of the operon has been demonstrated. 
Although in vitro reconstitution of AurF-like protein MgoC failed, feeding studies demonstrating the in 
vivo activity of MgoC suggest that its electron transfer mechanism is similar to AurF and other 
structurally similar diiron monooxygenases. However, plasmid stability issues mar the heterologous 
expression of the cluster in E. coli. These issues can be solved by judicious host and vector selection. 
Parallel to the heterologous expression product detection experiments, a method was developed 
based on reduction/diazotization-coupling in order to detect compound in the native host. This led to a 
possible peak in the native host, which is produced in low level. The low production is characteristic of a 
signaling/induction molecule, but it could also be due to other issues such as cluster protein expression 
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or substrate availability.  For further feeding and enzymatic studies, aminohydroxyphenylalanine 
compounds were prepared via chemoenzymatic means and characterized. In the end, this work 
supports the efforts in discovering the identity and chemical characterization of the Mangotoxin 
compound. However, further follow-up work is required for definitive identification and isolation of the 
gene product of this cluster. 
3.8. Materials and Methods 
 
Materials 
Unless otherwise noted, all reagents were obtained from either Sigma-Aldrich (St. Louis, MO), 
Fisher Scientific (Pittsburg, PA), or Gold Biotechnology (St. Louis, MO).  
Cloning and Standard DNA Manipulations 
 
All oligonucleotides were obtained from Integrated DNA Technologies (Coralville, IA), while 
restriction enzymes, DNA polymerases and other cloning-related enzymes were purchased from New 
England Biolabs (Ipswitch, MA). Restriction/ligation cloning was performed according to standard 
protocols.  For antibiotic usage, 1000x stock solutions of ampicillin (100 mg/mL), kanamycin (50 mg/mL) 
and gentamycin (10 mg/mL) were used.  To isolate genomic DNA from P. syringae , the Wizard Genomic 
DNA purification kit from Promega (Fitchberg, WI) was used. Plasmids were isolated from E. coli using 
the QIAprep Spin Miniprep kit (Qiagen, Valencia, CA), while yeast plasmids were isolated using the 
Zymoprep II kit (Zymo Research, Irvine, CA). Typical PCR conditions used 25 µL Buffer G (Epicentre 
Technologies, Madison, WI), 50 pmol of each primer, 1 unit of Phusion DNA polymerase, and 0.5-1 µL of 
template DNA. Annealing and elongation conditions were optimized based on the melting temperature 
of the primers and the lengths of the PCR products desired.  To create the T7 promoter-based 
constructs, individual Mangotoxin genes were cloned from the genomic DNA of P. syringae by PCR with 
appropriate restriction sites. PCR products were then purified and digested with the appropriate 
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restriction enzymes and ligated to similarly digested pET28a vectors (Novagen, Darmstadt, Germany) . 
Similar methods were used to clone out Trc-promoter constructs using pTrc99a as a vector (Amersham 
Biosciences, Piscataway, NJ).  Both E. coli and P. syringae were transformed according to standard 
electroporation protocols, using 0.2 cm cuvettes at a resistivity of 250 Ω and voltage of 2.5 kV. For E. 
coli, electrocompetent cells were prepared according to common protocols. Similarly, P. syringae 
competent cells were made using protocols developed by Schweizer et al.37  
DNA Assembler 
DNA assembler was performed according to the protocols found in literature.10 Briefly, primers 
were designed to create PCR products with 40bp - 1kb overlaps to previous and succeeding fragments 
and amplified using PCR. Around 100 ng of each PCR fragment was electroporated into the S.cerevesiae 
strain HZ848 and recovered in 1 mL YPAD media. 30, 100 and 200 µL of cells were then replated on SC-
Ura plates and left to grow at 30 ⁰C for two days. Colonies were picked and yeast plasmid DNA was 
isolated retransformed into E. coli DH5α for amplification. Plasmids were again isolated from E. coli by 
miniprep and confirmed by digestion analysis and sequencing.  
Gibson Assembly 
The Gibson Assembly protocol was performed as found in literature. 9 50-100 ng of each 
fragment was added to 15 µL of the Gibson premix. The assembly was incubated at 50C for 1 hour, and 
0.5 µL of the product was retransformed into E. coli DH5α. Plasmids were isolated using the QIAprep 
Spin Miniprep kit and confirmed by digestion analysis and sequencing. For expression studies, plasmids 
were cloned into either BL21 (DE3) or BAP1. To create the T7-based operon by Gibson assembly, pET28a 
was digested with HindIII and NcoI to linearize the vector. PCR was then used to amplify the fragments 
from genomic DNA (for the operon based construct) or from the individually cloned pET28a-genes using 
the appropriate primers.  
 
 
 
75 
 
In vivo assay for heterologous production of Mangotoxin 
BL21 (DE3) or BAP1 cells containing plasmids of interest were grown in TB media at 37⁰C with 
shaking at 250 rpm until their OD600 reached a value of 0.6-0.8. Cells were then induced with IPTG (0.5 
mM final concentration) and left to grow overnight at 30⁰C under identical shaking conditions. Cultures 
were then pelleted by centrifugation and washed twice with AurF assay buffer (25 mM MOPS, 8 g/L 
NaCl, 1 g/L KCl and 2 g/L glucose, pH 7.2).38 The cells were then resuspended in the AurF assay buffer to 
a final OD600 of 10 in 100 mL total volume. Substrates were added to a final concentration of 250 µM to 
start the reaction. The cells were allowed to react the substrates at 30⁰C with timepoints taken every 
hour for 4 hours.  A final overnight timepoint was taken the next day.   
Extraction of metabolites from resting cells 
An overnight culture of E. coli was inoculated into 500 mL of Terrific Broth with the appropriate 
antibiotic (Kanamycin or Ampicillin) and allowed to grow to saturation at 30C overnight. Cells were 
collected by centrifugation. The remaining media was acidified by addition of concentrated HCl until the 
pH reached approximately 1. The media was then extracted thrice with 200 mL of ethyl acetate, dried 
with sodium sulfate, and concentrated by rotary evaporation. The extract was then reconstituted with 1 
mL of methanol, and analyzed by HPLC. For P. syringae cultures, similar methods were used, except that 
the innoculum culture was grown to saturation after 2 days of growth, and King’s Media B was used to 
grow the culture for 3 days at 30C instead of overnight.  Additionally, pelleted cells from the 
Pseudomonas culture were extracted by resuspension with methanol and concentrated by rotary 
evaporation.  
Reduction/Diazotization/Coupling Protocol 
 To proceed with the reduction reaction,  100 µL of concentrated media or cell extract, 40 µL of 
HCl and a small amount of Zn powder was added. This mixture was heated at 70C for 15-30 minutes to 
complete the reduction. Bubbling and frothing indicated that the reaction was proceeding. The sample 
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was cooled to room temperature, centrifuged down and transferred to a new container. The 
diazotization reaction was performed by adding 40 µL of 1 mg/mL NaNO2 was added to an acidic 
solution of either the reduced compound, or a non-reduced sample. After 3 minutes of incubation, 40 µL 
of 5 mg/mL ammonium sulfamate was added to destroy the remaining nitrous acid. After a further 3 
minutes, the Bratton-Marshall reagent was added to develop the color of the compounds. Compounds 
were then centrifuged to precipitate out contaminants and analyzed by HPLC or by microplate readers. 
Synthesis of AHPs 
L-DOPA (50 mg, 250 µmol) and L-Cysteine (45 mg, 375 µmol) were dissolved in 25 mL of 50 mM 
sodium phosphate buffer at pH 6.8. Mushroom tyrosinase was added to a concentration of 500 
units/mL, and oxygen was bubbled into the mixture for 4 hours at 25⁰C.36 The resulting pheomelanin 
was then acidified with acetic acid at pH 3, and kept at 4⁰C overnight. The precipitate was then collected 
by centrifugation and washed with 1% acetic acid twice, and once with acetone. The solid was then 
dried with P2O5 and weighed. To hydrolyze the pheomelanin to AHP, the pheomelanin was dissolved in 5 
mL of 57% HI with the addition of 100 mg of H3PO4. This was refluxed for 20 hours, evaporated and 
resuspended in 5 mL of 0.1 M HCl. Centrifugation of the final solution provided the sample which was 
verified by LC-MS analysis.  
HPLC methods 
 An Agilent 1100 HPLC with a corresponding UV/Vis detector and 
autosampler was used to detect and quantify changes in substrate and 
product concentrations. Reverse-phase HPLC was performed using an 
Agilent Zorbax SB-C18 column (250 mm x 3.5 mm) to separate 
compounds, with buffer A being 1% acetic acid, and buffer B being 
methanol. To enable better retention of polar products and substrates, the solvents all contained 2 mM 
of sodium 1-heptanesulfonic acid as an ion-pairing reagent. The program used 0.4 mL/min as the flow 
Time 
(min) 
Buffer A Buffer B 
0 90% 10% 
7 90% 10% 
8.5 75% 25% 
10 25% 75% 
14 90% 10% 
23 90% 10% 
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rate, and used the above method to separate compounds of interest. Compounds were detected using 
wavelengths of 240, 250, 268, 290 and 320 nm. Diazotized compounds were detected at 550 nm, as 
products of this reaction have unique strong absorbances at this wavelength. For LC-MS analysis, an 
Agilent 1100 LC-MS was used with identical conditions as above (with no ion-pairing reagents), but with 
a flow rate of 350 µL/min. ESI was used as an ionization source. 
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3.10. Tables and Supporting Information 
 
Table 3.1:  Strains and Cell types used in this chapter. 
 
Name Organism Notes/ Genotype 
Pseudomonas syringae pv. 
tomato DC3000 
Pseudomonas syringae  Contains the Mangotoxin operon. Used as the host for 
genomic DNA isolation and feeding studies. 
Pseudomonas syringae pv. 
syringae B728a 
Pseudomonas syringae  Contains the Mangotoxin operon. 
   
BL21 (DE3) Escherichia coli F
–
 ompT gal dcm lon hsdSB(rB
-
 mB
-
) λ(DE3 [lacI lacUV5-
T7 gene 1 ind1 sam7 nin5]) 
Used for protein expression and whole-cell tests 
BAP1 Escherichia coli [F
−
ompT hsdSB(rB
−
 mB
−
) gal dcm (DE3) ΔprpRBCD (sfp)]  
Based on BL21 (DE3), with an IPTG-inducible pptase 
Sfp from Bacillus subtilis. Reference: 
39
 
DH5α Escherichia coli  F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK- mK+), 
λ– 
 
Used for cloning and plasmid maintenance 
Top10 Escherichia coli F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 
nupG recA1 araD139 Δ(ara-leu)7697 galE15 galK16 
rpsL(Str
R
) endA1 λ
-
 
HZ848 Sacchromyces cerevesiae Derivative of YSG50 with Ura knocked out. 
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Table 3.2: Primers used for this study. 
 
Name Sequence Template Comments 
Primers used to construct Mangotoxin V1. Construct A 
A - Reverse GGA CGA CCC AAG GAC CTG CA 
P. syringae 
Genomic DNA 
 
B - Forward AGC GTG GTC AGG TAG CTG TC 
P. syringae 
Genomic DNA 
 
B - Reverse GCC GCA GGG TGA GAA CGG CC 
P. syringae 
Genomic DNA 
 
C - Forward GGA TGA GGC GTT CAT TGA TT 
P. syringae 
Genomic DNA 
 
C - Reverse GAG CAC AAT CTC CAG GCG CT 
P. syringae 
Genomic DNA 
 
D - Forward CAA CAT CAT GCG CTT CTT CA 
P. syringae 
Genomic DNA 
 
Forward A 
GGC CTA GAG GCC GTG GCC ACC ACG GCC CGG CCT 
GCC TTT CAT GAG CAC AGC AGA TCA GAC 
P. syringae 
Genomic DNA 
 
Reverse D 
TTA TAG CAC GTG ATG AAA AGG ACC CAG GTG GCA 
CTT TTC GTC AGC CAA ACA GGC TGC GCA 
P. syringae 
Genomic DNA 
 
Yeast Forward 
Long 
TGA CGG TGC GAT GAG TAA CGT GCG CAG CCT GTT 
TGG CTG ACG AAA AGT GCC ACC TGG GTC 
pRS416 URA selection marker, CEN/ARS origin 
Yeast Forward 
Short CGA AAA GTG CCA CCT GGG TC 
pRS416 URA selection marker, CEN/ARS origin 
Yeast Reverse 
TTT ATC AGG GTT ATT GTC TCA TGA GCG GAT ACA 
TAT TTG AAG TGA GTT TAG TAT ACA TGC 
pRS416 URA selection marker, CEN/ARS origin 
E. coli Ptrc 
Fragment 
Forward 
AAA CTG TAT TAT AAG TAA ATG CAT GTA TAC TAA 
ACT CAC TTC AAA TAT GTA TCC GCT CAT 
pTrc99a Amp Selection Marker, pBBR32 origin 
E. coli Ptrc 
Fragment 
Reverse 
CCT TGG CGT CCA ACC AGC GGC ACC AGC GGC GCC 
TGA GAG GCG CGT TGC TGG CGT TTT TCC 
pTrc99a Amp Selection Marker, pBBR32 origin 
Pseudomonas 
Helper Forward 
CAG GGG GGC GGA GCC TAT GGA AAA ACG CCA 
GCA ACG CGC CTC TCA GGC GCC GCT GGT GCC 
pUCP19  
Pseudomonas 
Helper Reverse 
TGT AAT TGC CAG CGC TTT GGG TCT GAT CTG CTG 
TGC TCA TGA AAG GCA GGC CGG GCC GTG 
pUCP19  
Primers used to clone individual genes from the Mangotoxin operon into pET28 and pTrc99a 
NcoI / HindIII 
ORF 5-F TAG ATC CCA TGG CGA TGA ATA AAT CAG CAG 
P. syringae 
Genomic DNA 
Cloned into pTrc99a 
NcoI / HindIII 
ORF 6-F TAG ATC CCA TGG CGA TGG ATG GCC TGC TGC 
P. syringae 
Genomic DNA 
Cloned into pTrc99a 
NcoI / HindIII 
ORF 7-F TAG ATC CCA TGG CGA TGA AGT ATC GAA CCC 
P. syringae 
Genomic DNA 
Cloned into pTrc99a 
EcoRI / XBaI 
ORF 8-F GAC CAT GGA ATT CAT GCG CAA ATC AGA TAG 
P. syringae 
Genomic DNA 
Cloned into pTrc99a 
NcoI / HindIII 
ORF 9-F TAG ATC CCA TGG CGA TGT ATT GTG AGA AAA 
P. syringae 
Genomic DNA 
Used to clone MgoB into pTrc99a/pet28a 
EcoRI / XBaI 
ORF 10-F GAC CAT GGA ATT CAT GTC GTT CAT CGA TGC 
P. syringae 
Genomic DNA 
Used to clone MgoC into pTrc99a 
NcoI / XBaI ORF 
11-F TAG ATC CCA TGG CGA TGA AGC GCC TGG AGA 
P. syringae 
Genomic DNA 
Used to clone MgoA into pTrc99a. 
NcoI / HindIII 
ORF 12-F TAG ATC CCA TGG CGA TGA ACC ATA TTC ACA 
P. syringae 
Genomic DNA 
Used to clone MgoD into pET28. 
NcoI / HindIII 
ORF 5-R ACA GCC AAG CTT TTA CTG GTT ACC CAG CAC 
P. syringae 
Genomic DNA 
Cloned into pTrc99a 
NcoI / HindIII 
ORF 6-R ACA GCC AAG CTT TCA AAC GAG TTC AGG CAG 
P. syringae 
Genomic DNA 
Cloned into pTrc99a 
NcoI / HindIII 
ORF 7-R ACA GCC AAG CTT TCA GCG AAC CGG ACG ACC 
P. syringae 
Genomic DNA 
Cloned into pTrc99a 
EcoRI / XBaI 
ORF 8-R GTC GAC TCT AGA TCA GGC GGG GGT ATT CTT 
P. syringae 
Genomic DNA 
Cloned into pTrc99a 
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Table 3.2 continued  
NcoI / HindIII 
ORF 9-R ACA GCC AAG CTT CTA CGC ACT GGC CTG CAT 
P. syringae 
Genomic DNA 
Used to clone MgoB into pTrc99a/pet28a 
EcoRI / XBaI 
ORF 10-R GTC GAC TCT AGA TCA TTG CAG CGA TCC CTG 
P. syringae 
Genomic DNA 
Used to clone MgoC into pTrc99a 
NcoI / XBaI ORF 
11-R GTC GAC TCT AGA TCA GAT GAA GTC GAT TTC 
P. syringae 
Genomic DNA 
Used to clone MgoA into pTrc99a. 
NcoI / HindIII 
ORF 12-R ACA GCC AAG CTT TCA GCC AAA CAG GCT GCG 
P. syringae 
Genomic DNA 
Used to clone MgoD into pET28. 
pEt28 
TomatoNRPS 
Fwd NdeI GCG GCA GCC ATA TGA AGC GCC TGG AGA TT 
P. syringae 
Genomic DNA 
Used to clone MgoA into pET28. 
pEt28 Fwd NdeI 
TomatoAurF GCG GCA GCC ATA TGT CGT TCA TCG ATG CG 
P. syringae 
Genomic DNA 
Used to clone MgoC into pET28. 
pEt28 Rev EcoRI 
TomatoAurF GGA GCT CGA ATT CTC ATT GCA GCG ATC C 
P. syringae 
Genomic DNA 
Used to clone MgoC into pET28. 
pEt28 
TomatoNRPS 
Rev NotI TCG AGT GCG GCC GCT CAG ATG AAG TCG ATT 
P. syringae 
Genomic DNA 
Used to clone MgoA into pET28. 
Primers used to construct the Master Helper Plasmid shuttle vector (also known as YEP – Yeast-E. coli-Pseudomonas) Construct B 
Yeast/Ecoli 
forward 
TCT GGC CTA GGC GGC CGC GAG ACT CTT AAT TAA 
CGA AAA GTG CCA CCT GGG TCC TTT TCA 
Mangotoxin V1  
Yeast/Ecoli 
Reverse 
ACT CTG CGA CAT CGT ATA ACG TTA CTG GTT TCA 
CAT TCA CCA CCG CGT TGC TGG CGT TTT 
Mangotoxin V1  
LacI Forward 
AGG GGG GCG GAG CCT ATG GAA AAA CGC CAG 
CAA CGC GGT GGT GAA TGT GAA ACC AGT AAC 
pTrc99a  
LacI Reverse 
CCT TGG CGT CCA ACC AGC GGC ACC AGC GGC GCC 
TGA GAG GTC ACT GCC CGC TTT CCA GTC 
pTrc99a  
Pseudomonas 
Forward 
CTG GCA CGA CAG GTT TCC CGA CTG GAA AGC GGG 
CAG TGA CCT CTC AGG CGC CGC TGG TGC 
pUCP19  
Pseudomonas 
Reverse 
CCA GGT GGC ACT TTT CGT TAA TTA AGA GTC TCG 
CGG CCG CCT AGG CCA GAT CCA GCG GCA 
pUCP19  
Generic primers used for both the T7 and Trc based Gibson assemblies. Construct D and F 
GibORF 9 Naked 
Rev 
GCACTGGCCTGCATCAGCGG pET28a-ORF 9 Binds only at the end of the gene.  
GibORF 10 
Naked Rev 
TCA TTG CAG CGA TCC CTG AAC CGG  pET28a-ORF 10 Binds only at the end of the gene.  
GibORF 11 
Naked Rev 
TCAGATGAAGTCGATTTCTTTCAGG pET28a-ORF 11 Binds only at the end of the gene.  
Primers used to construct the Mangotoxin genes with individual T7 promoters by Gibson assembly. See Figure 3.3E for the vector map. 
F ORF 9-10 
Gibson 
CCGCTGATGCAGGCCAGTGCGATGCGTCCGGCGTAGA
GGATCGAGATCTC 
pET28a-ORF 10 Contains the end of ORF 9 and the beginning of 
the T7 promoter  
F ORF 10-11 
Gibson 
CCGGTTCAGGGATCG 
CTGCAATGAGATGCGTCCGGCGTAGAGGATCGAGATC 
pET28a-ORF 11 Contains the end of ORF 10 and the beginning 
of the T7 promoter  
F ORF 11-12 
Gibson 
CCTGAAAGAAATCGACTTCATCTGAGATGCGTCCGGC
GTAGAGGATCGAGATCTC 
pET28a-ORF 12 Contains the end of ORF 11 and the beginning 
of the T7 promoter  
ORF 11 Gibson 
End Rev 
GTGGTGGTGGTGCTCGAGTGCGGCCGCAAGCTTTCAG
ATGAAGTCGATTTCTTTCAGG 
pET28a-ORF 11 Contains the end of ORF 11 and the beginning 
of the T7 terminator 
ORF 10 Gibson 
End Forward  
ATTTTGTTTAACTTTAAGAAGGAGATATACCATGGATG
TCGTTCATCGATGCGTG 
pET28a-ORF 10 Begins with the T7 Promoter from pET28a to 
construct the ORF 9 deletion 
Primers for cloning individual Trc promoters before each gene. 
GibTrc 9 start F 
GATCTGGCCTAGGCGGCCGCGAGACTCTTAATTAATTC 
TGG CAA ATA TTC TGA AAT GAG C 
pTrc99a-ORF 9 Overlapping region between the beginning of 
Master Helper Plasmid and pTrc promoter.  
GibTrc 9-10 F 
CCGCTGATGCAGGCCAGTGCTTC TGG CAA ATA TTC 
TGA AAT GAG C 
pTrc99a-ORF 10 Contains the end of ORF 9 and the beginning of 
the Trc promoter  
GibTrc 10-11 F 
CCG GTT CAG GGA TCG CTG CAA TGATTC TGG CAA 
ATA TTC TGA AAT GAG C 
pTrc99a-ORF 11 Contains the end of ORF 9 and the beginning of 
the Trc promoter 
GibTrc 11-12 F 
CCTGAAAGAAATCGACTTCATCTGATTC TGG CAA ATA 
TTC TGA AAT GAG C 
pTrc99a-ORF 12 Contains the end of ORF 9 and the beginning of 
the Trc promoter 
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Table 3.2 continued 
GibTrc 12 Rev 
AAAGGACCCAGGTGGCACTTTTCGTTAATTAATCAGCC
AAACAGGCTGCGCACGTTAC 
pTrc99a-ORF 12 Contains the end of ORF 12 and overlaps with 
Master Helper Plasmid. 
 
Primers used for qPCR of the Mangotoxin genes – See Figure 3.2 for genes to be amplified.  
Mangotoxin 1 
Set 1 Forward  TTC GGA ATC TTC GGA ATG GAG GCT 
P. syringae cDNA  
Mangotoxin 1 
Set 1 Reverse  AGG AGT AAT TGG CAG TCA GGG AGT 
P. syringae cDNA  
Mangotoxin 2 
Set 1 Forward  TTT AAG CTG ATG GTC AGG TCG GCA 
P. syringae cDNA  
Mangotoxin 2 
Set 1 Reverse  GCG CTT TCA TTC CGT ATT GGG ACA 
P. syringae cDNA  
Mangotoxin 3 
Set 1 Forward  ATC GTG GAG TTC CTT CTG CAC AGT 
P. syringae cDNA  
Mangotoxin 3 
Set 1 Reverse  TGG GCA CCT CAG GAC ATA CTG ATT 
P. syringae cDNA  
Mangotoxin 4 
Set 1 Forward  ATA CTC TTG CCT TGT GCT GCT CGT 
P. syringae cDNA  
Mangotoxin 4 
Set 1 Reverse  AGA CGC TGC TCA GGC TTG GAT TT 
P. syringae cDNA  
Mangotoxin 5 
Set 1 Forward  TGG AAA GCT CTT GAT TGG CCT TGC 
P. syringae cDNA  
Mangotoxin 5 
Set 1 Reverse  AGG TAT AGC GGT TGG CGT CAT TGT 
P. syringae cDNA  
Mangotoxin 6 
Set 1 Forward  TAC ACG GAG GTC ACA CAC CTG ATT 
P. syringae cDNA  
Mangotoxin 6 
Set 1 Reverse  CAG TTC AAG CGC CTT GAT CAC GTA 
P. syringae cDNA  
Mangotoxin 7 
Set 1 Forward  AAG CGA TTG CTG GAA ACC GAA TGG 
P. syringae cDNA  
Mangotoxin 7 
Set 1 Reverse  ACA CCC TTG TCC TGC ACG TAT TCT 
P. syringae cDNA  
Mangotoxin 8 
Set 1 Forward  GTT GTA CGC CAA GAC CCA CAA CAA 
P. syringae cDNA  
Mangotoxin 8 
Set 1 Reverse  ACT GCC AGT GGT CAT CCT GAG AAA 
P. syringae cDNA  
Mangotoxin 9 
Set 1 Forward  GCG CTT CAT CGA ACT GCA GAA ACA 
P. syringae cDNA  
Mangotoxin 9 
Set 1 Reverse  AAT GCT CTG GAA CAT CAG CGG GAT 
P. syringae cDNA  
Mangotoxin 10 
Set 1 Forward  AGA ACG GCT TCG ACT TTA CGC TGA 
P. syringae cDNA  
Mangotoxin 10 
Set 1 Reverse  GAA GAA GCG CAT GAT GTT GCC GAT 
P. syringae cDNA  
Mangotoxin 11 
Set 3 Forward  CAC ATC GTT GAA GCG CTG CTG AAT 
P. syringae cDNA  
Mangotoxin 11 
Set 3 Reverse  AAA CCT TCA CCC GAC TCA AGT CCA 
P. syringae cDNA  
Mangotoxin 12 
Set 1 Forward  TAT TCC GGC ATT GGA GAG CAC TGA 
P. syringae cDNA  
Mangotoxin 12 
Set 1 Reverse  ATC GCC ACA TTG CCA TCC TTG AAC 
P. syringae cDNA  
Gyrase A Set 2 
Forward Primer TAT TTC CTG TCG CCA GAA CAG GCT 
P. syringae cDNA  
Gyrase A Set 2 
Reverse Primer TTT CCT GGT ACT CAC CCA GCA GTT 
P. syringae cDNA  
 
